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Introduction
   10 
THERAPEUTIC GENE DELIVERY 
 
Several basic terms and definitions tightly connected with therapeutic gene delivery need to 
be addressed prior to discussing polymeric gene delivery systems, which are subject of this 
dissertation. Polycations were synthesized and characterized here with the perspective to 
generate therapeutic tools in the biomedical field in the foreseeable future.  
 
 
What is gene therapy? 
 
It is a rather young therapeutic direction, which bases its curative attempts on causal 
principles, namely on correction of gene malfunction or the absence of functional gene. A 
broad variety of diseases which have their origin in some hereditary or acquired gene defects 
can be treated more directly and effectively with gene therapy. If this therapeutical gene 
“reparation” approach is successful, the disease symptoms will be eliminated more 
productively than it could be done via traditional medicinal methods, directed against the 
consequences of gene malfunction. The correction of gene defects can be achieved by gene 
replacement, removal or silencing of genes in the tissue of interest. Therapeutic gene delivery 
is a practical tool for achieving the goals of gene therapy. 
 
Where can therapeutic gene delivery be applied? 
 
Here are some examples from the broad range of severe diseases which can be potentially 
treated or even cured with gene therapy: cystic fibrosis [1], HIV [2], haemophilia [3], 
cardiovascular disorders [4], Wiskott-Aldrich Syndrom [5] and cancer [6, 7]. 
 
  11 
 
Two basic principles of gene “reparation” in the cell: 
 
To address the defect gene some agent should be brought into the cell. The process of 
deliberate introduction of nucleic acids into the eukaryotic cell is usually defined as 
transfection. Material transfected, or introduced, into the cell can be DNA or RNA. 
Depending on the type of nucleic acid their further desired destination is different. So DNA 
needs to reach and enter the nucleus (Figure 1), whereas RNA is performing its function 
already in cytosol (Figure 2). 
The transfected gene in form of DNA, would be as well supposed to perform “gene 
expression” after locating itself in cell nucleus, whereas RNA introduction mostly results in 
“gene silencing”, or in other words would be blocking some “gene expression” or gene 
expression products at the level of translation. The process within living cells that moderates 
the activity of their genes is called RNA interference (RNAi) and was first described in live 
experiment in 1998 [8].  
Both, gene expression after DNA, and gene silencing after RNA delivery are considered to be 
equivalent therapeutic approaches in the scope of gene therapy.  
 
 
Figure 1: DNA delivery to the cell by polycationic vectors, the DNA needs to reach nucleus, where it follows 
the biological amplification mechanism (coding DNA ›  mRNA › therapeutic protein) to achieve required 
therapeutic effect. [9] 
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Nevertheless RNA is evaluated as a more long lasting gene therapy tool [10].  
 
 
 
Figure 2: key steps of siRNA delivery into the cell and its “silencing” action pattern [10] 
 
In our study we use plasmid DNA (pDNA) of a Luciferase coding gene (or reporter gene) as a 
model gene for transfection. The stably transfected cells which can produce Luciferase 
enzyme due to successful pDNA delivery into the nucleus, are treated with anti-Luceferase 
small interfering RNA (siRNA). The delivery efficacy of DNA and siRNA with polycationic 
carriers can be monitored as increased or decreased luminescence of the cells after treatment 
respectively.  
 
CHARACTERISTICS OF CANCER TISSUE AS ONE OF GENE DELIVERY 
OBJECTIVES 
Here some specific characteristics of cancer tissue, as one of the mainstream interests for 
therapeutic gene delivery, will be discussed in short. 
 
Acidification of tumor tissue 
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One of tumor tissue characteristics is an increased acidity 6.72 - 7.01 in comparison to a 
healthy tissue with pH 7.3-7.4. Tumors metabolize glucose to acidic products faster than 
normal cells, hence increasing their acidity very rapidly [11]. Nevertheless such condition can 
appear in pathological state only at simultaneous lack of oxygen.   
Apart of acidification of tumor tissue due to accumulating metabolite products, which can be 
exploited for targeting with pH-sensitive vehicles, there is also acidification inside the tumor 
cell compartments, which is not being straight forward and has a disadvatageous impact on 
chemotherapy. For example the MDR breast cancer cells have less acidic cytoplasm than drug 
sensitive cells, but more acidic compartmental system. In this way, among others, tissues 
achieve their multi drug resistance (MDR) in tumor therapy due to capturing antitumor agents 
in endosomes and lysosoms [12]. Another self-protecting mechanism of MDR tumor cells is 
P-glycoprotein efflux-pump counteracting the accumulation of chemotherapeutical agents at 
the site of action [13].  
On the other hand tumor acidity as a specific tissue feature can be exploited for therapeutic 
gene delivery issues, selectively tuning the disruptive activity of nano-vehicles in targeted 
cells [14, 15]. 
 
Figure 3: Schematic view of (a) a drug-resistant cell and (b) a drug-sensitive tumor cell 
showing the pH values measured in the various compartments [16]. 
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Tumor cell growth phases  
 
The control mechanism orchestrating the cell growth cycle is a factor which has to be 
involved in cell tumorogenic activity, as one of the features of cancer is an excessive cell 
proliferation with reduced control over differentiation or cell death [17]. After mitosis the 
daughter cells may grow to non-dividing cells or turn to another cell life cycle with G1, S and 
G2 phase. In case of tumor cells the farther multiple division cycles will be pursuit after 
mitosis. 
  
 
 
Figure 4: Cell life cycle [18]. 
 
Dependant on the cell-cycle phase of the cells to be transfected, their internalization ability, 
endocytosis and thus the transfection efficacy of gene carriers can vary [19-22].  The example 
below shows the following distribution of model gene expression after transfection performed 
in different cell cycle phases. Depandant on proportion of cells in different cell cycle phases 
in tumor tissue as a unit, the efficacy of a therapeutic agent would vary. 
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Figure 5: Cell cycle dependence of DNA-PEI transfection efficacy [19]. 
 
There is another rather converse finding of Tseng et al., where during late G1 phase 1.5 times 
more polyplexes are uptaken than during G2/M phases [22]. But if the cells were at S or G2/M 
phases at the beginning of transfection process, approximately 30-fold or more than 500-fold 
higher transgene expression could be achieved than with the cells in G1 phase [19]. The cell 
nature should be taken into account during evaluation of cell cycle impact on transfection 
results. 
 
Enhanced Permeation and Retention (EPR) Effect 
 
Tumor tissue is known for its extensively fast growth. Due to this fact, the vessels which need 
to be built for blood supply of the new tissue are growing in accelerated regime. The vessel 
walls in tumor area are not as tightly constructed as in healthy tissue, showing multiple 
openings able to let through some nano-scaled objects. The grade of tumor tissue 
vascularisation is also above normal. Moreover the lymphatic drainage of tumor tissue is 
absent, herewith limiting the evacuation of infiltrated objects. 
Enhanced Permeation and Retention (EPR) Effect occurs as follows: a nano-sized object, 
possessing no special attraction forces to a certain tissue, or predisposition to conglutinate or 
to be absorbed during circulation in blood steam, would not be able to get into the tissue 
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surrounded with healthy vessels and would not be lost from circulation till it billiary or renally 
eliminated.  The journey through the cardiovascular system would continue till the nano-
object meets the leaky vessels of tumor. Here it can passively leave the vessel and enter the 
malignant tissue, accumulating there due to intensified blood perfusion of tumor and lacking 
lymphatic drainage [23]. On this principle gene carriers without targeting moiety can be to 
some extent addressed to the tumor tissue “ignoring” healthy organs, in this way reducing the 
off-target toxicity. This passive targeting can in no case completely replace the targeting 
moeties but can only give some assistance to generalized drug application indicated for tumor 
tissue.  
 
 
 
Figure 6: Enhanced Permeation and Retention Effect. Passive targeting of tumor tissue due to enhanced 
fenestration of tumor vasculature: preferential extravasation of nanovehicles from circulation into tumor and 
acculmulation there due to absent lymphatic drainage [23] 
 
 
CLASSICAL EXAMPLES OF POLYCATIONIC MATERIALS FOR GENE 
PACKAGING 
 
Advantages of polymeric gene carriers over viruses and liposomes 
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An ideal polymeric vector should combine the advantages of high performance gene delivery 
of viral vectors, and at the same time show reduced toxicity in comparison with cationic 
lipids. Immuno- and pathogenicity as latent risk of viral carriers should be eliminated, as well 
as sufficient load capacity for genetic cargo should be ensured [24-26].  
Another advantage of polymeric vectors is the possibility to tailor them individually 
according to the delivery system design needs, enjoying the privilege of synthesis 
controllability, reproducibility and potentially easier up-scale-ability of manufacturing 
process.  
 
Self-assembly principle  
 
Most water soluble polycations have protonated nitrogens in their structure which interact 
with negative phosphates of nucleic acids due to charge to charge interaction. In this manner 
self-assembled nano-carriers are created by common pipetting of two solutions together. The 
polymer complexes with DNA, or polyplexes, gain more or less positively charged surface, 
depending on polymer structure and excess of polymeric nitrogen in nitrogen to phosphate 
ratio of the final nano-scaled construct (N/P). 
 
Classical representatives of polycationic materials for gene delivery 
 
A short overview of well known mainstream polycations with alterating branching grade, 
deriving from different polymeric classes is presented below. 
 
Poly(ethylene imine) (branched PEI 25 kDa) 
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PEI was described 1995 by Boussif et al. [27] as “proton sponge”, where every third polymer 
atom is a protonable amino nitrogen. The primary amines are preferably protonated already at 
physiological pH, the higher order amines have a broader protonation capacity [28]. This 
feature is favourable for endosomal escape, so that no additional transfection helpers like 
chloroquin are needed for PEI-DNA complexes [29, 30].  
PEI is a branched polymer but it lacks a definite symmetrical central point [28], the construct 
retains a spherical form and is rather inflexible in its interactions with nucleic acids [31]. 
The highest efficacy of PEI in transfection was observed for polymer molecular weights (Mw) 
between 5 and 25 kDa [32], whereas higher Mw appeared to be more toxic [33]. 
Microcalorimetric data support the charge based self-assembly process with DNA [34]. 
 
 
 
Figure 7: Branched PEI [32] 
 
 
Poly(L-Lysine) (linear PLL) 
 
Leammli et al. first visualized the ability of polylysine to compact DNA into a tight structure 
1975 [35]. PLL is a liner polycation built from lysine repeating units. It has rather poor 
buffering capacity under pH 8, as only primary amines are available for protonation. The 
ability to transfect cells is also lower than those of branched PEI [28]. Transfection efficacy 
was correlating with toxicity of PLL increasing towards higher Mw [29]. The reduced 
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transfection efficiency in some cases is believed to be caused by the cell death of transfected 
cells, lowering the general expression rate of a model gene.  
The complexation ability of linear PLL assessed with ethidium bromide assay was less 
pronounced than in case of PEI [28].  The ability to disrupt endosomes is very low in 
comparisson to proton-sponge active polymers like PEI [36].       
        
 
Figure 8: Polylisine [25] 
  
 
Poly(2-(dimethyl amino)ethyl methacrylate), pDMAEMA  
 
pDMAEMA is a linear polymer, its acrylate backbone is non-biodegradable, the ester group 
in the side chain can be hydrolysed. The hydrolytic stability of polycation increases with 
growing polymerization grade [37]. The average pKa is about 7.5, so the charge availability at 
physiological pH is available not in full extent [37]. This charge intensity is however 
sufficient for polymer-DNA complex formation and DNA protection, but easily dissociable 
once entering the cytosol [38]. Transfection efficacy of pDMAEMA Mw 309 kDa was better 
than of PLL 120 kDa in COS-7 cells. The toxicity of long chain polymers is growing 
accordingly, setting a limit for using them as non-viral vectors [39]. 
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Figure 9: pDMAEMA [39] 
 
 
STRATEGIES FOR IMPROVEMENT OF POLYMERIC CARRIERS  
 
“The ideal nanovehicular vector would achieve long circulation time, low immunogenicity, 
good biocompatibility, selective targeting, efficient penetration of physiological barriers such 
as vascular endothelium and the blood–brain barrier, external activation or self-regulating 
drug release, and have no clinical side-effects”[23].  
Ideal vector has not been created yet, but the approaches to lend some of its properties to 
already existing polymers can be traced in optimization attempts of different working groups. 
Some of improvement strategies are discussed below: 
 
Prolonged circulation time 
 
Poly(ethylene glycol) (PEG) is a linear polyether diol, which combines several essential 
properties like biocompatibility, good water and organic medium solubility; it is non-toxic 
and was approved by FDA for internal administration [40].  
Conjugation of PEG to different kinds of polycations was found to be beneficial. So e.g. the 
masking effect of PEG in PEG-PLL conjugate was demonstrated previously resulting to 
decreased cell adherence of polyplexes [41]. This effect resulted in transfection reduction in 
vitro, but in more physiological conditins PEG-PLL conjugates were more successful and 
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prevented polyplex aggregation [42, 43]. Longer circulation time of polyplexes with 
“indifferent” behavior in blood stream would enlarge their accumulation in tumor due to EPR 
effect [44]. Nevertheless activation of anti-PEG IgM after multiple exposition to PEGylated 
vectors was reported [45]. It resulted in “accelerated blood clearance” (ABC) phenomenon, 
the second dose of vector was removed from circulation much more rapidly, so that the vector 
could not develop the expected performance achieved initially.  
 
 
Increased biocompatibility 
 
It was manifold stated previously that transfecting agents with high molecular weight are 
being more effective, but also more toxic. How can transfection performance be retained 
whereas toxicity reduced?  
One of the approaches is to reduce the Mw of involved polycation, as the most toxicity is 
charge associated [33]. Problematic of this toxicity reduction approach is a lower capability of 
low molecular weight vectors to compact and protect DNA from enzymatic degradation. To 
avoid this handicap of short chain polycations, most authors design complex polymeric 
constructs containing low toxic polycationic parts reversibly bound via biodegradable link to 
each other or an alternative backbone with good biocompatibility. Some examples could be: 
the S-S bound PEI-PEG vector, where PEI of 2 kDa was playing role of element for DNA 
complexation [46] or pDMAEMA side chains of pDMAEMA under 30 kDa bound via 
hydrolysable linkers to pHEMA backbone [47]. In both cases the linked structure had a higher 
gene delivery performance than its components taken apart, as well as a potential to be 
degraded into smaller products eliminable from the body and hence less toxic.  
 
Increased membrane activity 
  22 
 
Under membrane activity both outer cellular membrane and intracellular compartment 
membrane (endosomal and lysosomal membrane) are interaction surfaces which will be 
involved in discussion. 
Attraction to and interaction with cellular membrane are of critical importance for productive 
carrier uptake into the cell. At least partial positive charge of polyplex surface is needed to 
attract nano-vehicle to negatively charged cell membranes. Neutral or negatively charged 
polymers would have difficulties to do so. After the gene delivery system and cell surface get 
in contact the uptake into the cell is needed for further processing of polymer protected gene. 
Endocytosis is believed to be the most frequent uptake mechanisms [48], whereas local 
destabilisation of membrane leading to enchanced penetrability is also considered to be 
important (e.g. for pDMAEMA [39]).  
When the polyplex is taken up it meets next hurdle – it is captured in endosomal compartment 
and needs to escape before it is digested. To break out it needs certain disruptive forces, e.g. 
buffering capacity, which is based on ability of polymer to act as “proton sponge” and finally 
disrupt swollen compartment [49].  Broad buffering capacity is considered to be a good 
prerequisite of disruption activity.  
Another way to increase membrane activity is the introduction of hydrophobic component, 
which may integrate itself in membrane phospholipid bilayer, hence serving as anchorage and 
membrane penetrability enhancer. This feature was borrowed from the liposomal structure, 
known for its excellent membrane penetrability due to membrane fusion [50, 51].  
 
 
OBJECTIVE OF THE STUDY 
 
Chapter 1 gives a short introduction on therapeutic gene delivery, defining constituent parts 
associated with it, explaining differences in DNA and siRNA approach to “curing” of gene 
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malfunction. Among the variety of severe diseases building a scope of gene therapy, special 
focus is given on cancer tissue characteristics, such as acidification and EPR-effect, which 
have essential impact on nano-carrier delivery. Classical representatives of branched and 
linear polycationic vectors are shortly introduced: PEI, PLL and pDMAEMA. Basic strategies 
for polymeric carriers’ improvement are also being discussed in this chapter.  
 
Chapter 2 aimes to investigate the alterations in polymeric transfection caused by changes in 
the extracellular pH during both uptake and culture phases. The study focuses on polymeric 
and cellular characteristics and their respond to pH decrease. The model polycations with 
different physicochemical properties PEI 25 kDa and PLL 27 kDa are being monitored 
according to their proton buffering capacity and ionization, polyplex size, surface charge, and 
decomplexation ability. The pH induced cellular characteristic alterations, reflected in cellular 
uptake, cell cycle phases, and intracellular pH environment, are also investigated.  
 
Chapter 3 explores the impact of hydrophilic-hydrophobic-polycationic composition in tri-
block polymer on its physicochemical properties. The aim of the study is to establish 
correlation between polymer structure and siRNA transfection efficacy. A library of PEG-
PCl-PEI block-copolymers was synthesized, modifying the branching grade and PCL-
segment length, in order to increase the carrier colloidal stability and ability to escape from 
endosomal compartments.  
 
Chapter 4 deals with transfection efficacy optimization of low molecular weight 
pDMAEMA-vectors for DNA delivery. It is hypothesized that minimizing of polycationic 
chain length leads to a better vector biocompatibility, at the same time the pHEMA-grafting to 
short polycationic chain can improve its poor performance in vitro. A library of pDMAEMA-
b-pHEMA diblock-copolymers with varying co-block proportions is tested towards their 
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ability to enhance transgenic expression in comparison to a low molecular weight homo-
pDMAEMA.  
 
In Chapter 5 it is hypothesized that the conformational rearrangements of polymeric carriers 
in aqueous solution have impact on thermodynamics of polymer-DNA binding, what could be 
a reason for transfection efficacy alterations within the low molecular weight pDMAEMA-b-
pHEMA diblock-copolymer family. The pHEMA co-part is supposed to increase the glas 
transition temperature of diblock-copolymers, reducing the chain mobility and hence 
impeding the folding readiness of a linear construct. The better surface assesibility of 
polycation nitrogens in a non-folded rigid construct is supposed to result in more energetically 
favourable polymer interaction with DNA.  
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ABSTRACT 
Although polymers, polyplexes, and cells are exposed to various extracellular and 
intracellular pH environments during polyplex preparation and polymeric transfection, the 
impact of environmental pH on polymeric transfection has not yet been investigated. This 
study aims to understand the influence of environmental pH on polymeric transfection by 
modulating the pH of the transfection medium or the culture medium. Changes in the 
extracellular pH affected polymeric transfection by way of complex factors such as pH 
induced changes in polymer characteristics (e.g., proton buffering capacity and ionization), 
polyplex characteristics (e.g., size, surface charge, and decomplexation), and cellular 
characteristics (e.g., cellular uptake, cell cycle phases, and intracellular pH environment). 
Notably, acidic medium delayed endocytosis, endosomal acidification, cytosolic release, and 
decomplexation of polyplexes, thereby negatively affecting gene expression. However, acidic 
medium inhibited mitosis and reduced dilution of gene expression, resulting in increased 
transfection efficiency. Compared to pH 7.4 medium, acidic transfection medium reduced 
gene expression 1.6~7.7-fold whereas acidic culture medium enhanced transfection efficiency 
2.1~2.6-fold. Polymeric transfection was affected more by the culture medium than by the 
transfection medium. Understanding the effects of extracellular pH during polymeric 
transfection may stimulate new strategies for determining effective and safe polymeric gene 
carriers. 
 
1. Introduction 
A great effort for developing effective polymeric vectors has focused primarily on cellular 
receptor targeting [1-3], endosomal escape [4-6], cytosolic transport [7-9], nuclear import [8, 
10, 11], and decomplexation [12-17]. The effects of the transfection environment with respect 
to proteins [18-20], ions [3, 18, 21-23], pH [13, 16, 17, 24, 25], reduction/oxidation potentials 
[14, 15, 26], and hypoxia [14, 27-29] have also been investigated in relation to polyplex 
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preparation and polymeric transfection. Among these effectors, we focused on pH because the 
solution (or medium) pH, extracellular pH, and intracellular pH can all modify characteristics 
of polymers, polyplexes, and cells. 
When dissolving polycations and pDNA or preparing polycation/pDNA complexes, buffer 
solutions, saline, and/or deionized water have all been routinely used. These solutions can be 
artificially modulated by adjusting the pH, which can affect the ionization of polycations and 
pDNA. A change in ionization influences the physicochemical characteristics (e.g., particle 
size and surface charge) and complexation/decomplexation behavior of polyplexes [30]. 
The aforementioned solution can be described as the “extracellular medium,” especially when 
the medium surrounds cells in vitro and in vivo. The extracellular medium used for laboratory 
cell cultures can be modulated by adding or removing various components and by adjusting 
the pH to fit specific purposes. However, in vivo extracellular environments are 
predominantly affected by pathological differences. The extracellular pH of healthy organs is 
close to pH 7.4 (e.g., pH 7.4 for normal blood, pH 7.2 for brain [31], and pH 7.5 for heart 
[32]). Under certain pathological conditions, the extracellular pH can become acidic (e.g., 
approximately pH 6.4-6.8 for solid tumors [33], pH 6.4 for brain ischemia [31], and pH 6.8 
for heart ischemia [32]). The extracellular pH can modulate various biological functions, such 
as gene expression [34], growth rate [35], viability [36], cellular uptake [37], endocytosis [37, 
38], exocytosis [38], and lysosomal trafficking [39]. However, the effects of pH on polymeric 
transfection have rarely been studied.  
The intracellular environment is not fixed at a specific pH value. Subcellular compartments 
such as endosomes (pH 5-7), lysosomes (pH 4-5), the cytosol (pH 6.7-7.1), and the nucleus 
(pH 7.1-7.2) have separate pH environments [40-42]. Upon endosomal formation, the pH 
drops with maturation from early to late forms. In particular, the late endosomal and 
lysosomal pHs are quite distinctive depending on a cell’s drug resistance and/or sensitivity 
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(e.g., approximately pH 6.0 and pH < 5.8, respectively, for drug-resistant MCF7 cells and pH 
6.5 and pH > 5.8, respectively, for drug-sensitive MCF7 cells) [40, 41]. 
Regarding intracellular pH, polymers for polymeric vectors have been designed primarily to 
target endolysosomal pathways by either disrupting endolysosomal membranes [4-6] or 
degrading polycations [16, 17]. 
As described, the pH environment affects characteristics of polymers, polyplexes, and cells. 
However, after polyplexes or cells are exposed to certain medium or extracellular pH values, 
it is unknown how the changed pH environments influence polymers, polyplexes, or cells 
during cellular internalization and intracellular trafficking of polyplexes. Thus, this research 
aims to understand how extracellular pH affects polyplexes and polymeric transfection. This 
study examines whether the effects of extracellular pH on transfection efficiency are caused 
by polyplex/polymer characteristics (e.g., pH-induced changes in surface charge, particle size, 
and decomplexation of polycation/pDNA complexes and proton buffering capacity of 
polymers) and/or cellular characteristics (e.g., cellular uptake of polyplexes, cell cycle phases, 
and cell viability). Branched polyethyleneimine (PEI) and poly(L-lysine) (PLL) were selected 
as model polymers due to their different degrees of ionization in response to environmental 
pH changes. Four pHs (i.e., pHs 7.4, 7.0, 6.7, and 6.3) were selected between the 
physiological pH 7.4 and the pathological lowest possible acidic pH 6.3. 
 
 
2. Materials and methods 
2.1. Materials 
PLL hydrobromide (Mw(viscosity) 27.4 kDa), branched PEI (Mw 25 kDa, Mn 10 kDa), 3- (4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), RPMI1640 medium, Ca2+-
free and Mg2+-free Dulbecco’s phosphate buffered saline (DPBS), fluorescein isothiocyanate 
(FITC), rhodamine B isothiocyanate (RITC), triethylamine (TEA), dimethyl sulfoxide 
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(DMSO), 4-(2-hydroxy-ethyl)-1-piperazine (HEPES), 2-(Nmorpholino) ethanesulfonic acid 
(MES), nigericin, monensin, glucose, sodium bicarbonate, propidium iodide (PI), doxorubicin 
(DOX) (or adriamycin (ADR)), Triton®X-100, recombinant human insulin, and 
paraformaldehyde (PFA) were purchased from Sigma- Aldrich Companies (St. Louis, MO). 
Plasmid DNA (pDNA) encoding firefly luciferase (gWiz-Luc or pLuc) was purchased from 
Aldevron, Inc. (Fargo, ND). Fetal bovine serum (FBS), penicillin-streptomycin antibiotics, 
trypsin-EDTA, RNase, and YOYO-1 were purchased from Invitrogen, Inc. (Carlsbad, CA). 
The luciferase assay kit and BCATM protein assay kit were bought from Promega Corporation 
(Madison, WI) and Pierce Biotechnology, Inc. (Rockford, IL), respectively. 
 
2.2. Cells and cell culture 
MCF7 cells (a human breast adenocarcinoma cell line), MCF7/ADR-RES cells (a DOX 
induced multidrug resistant subline of MCF7), and MES-SA cells (a human uterus sarcoma 
cell line) were used. The cells were cultured in RPMI1640 medium supplemented with 
glucose (2 g/L) and 10% heat-inactivated FBS under humidified air containing 5% CO2 at 
37°C. Additionally, insulin (4 mg/L) was added to RPMI1640 medium for MCF7 and 
MCF7/ADR-RES cells. As previously reported [43], to maintain multidrug resistance (MDR) 
of MCF7/ADR-RES cells, DOX (400 ng/mL) was added once weekly. 
 
2.3. Acid-base titration of polycations 
Acid-base titration was performed to monitor the proton buffering capacity of polymeric gene 
carriers as previously reported [4]. PLL·HBr and PEI (10 mg) were dissolved in NaCl 
aqueous solution (150 mM; 10 mL) with 1 N NaOH (aq.) (100 µ L). The polymer solution (1 
mg/mL; 3 mL) was titrated with 0.1 N HCl at room temperature (RT). The pH changes of 
polymer solutions were monitored. 
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2.4. Preparation and physicochemical characteristics of polyplexes 
As previously reported [3, 43], polyplexes were prepared using pDNA and polycations (i.e., 
PEI and PLL) in HEPES buffer (20 mM, pH 7.4) supplemented with 5% glucose (HBG). 
After mixing pDNA and polycations using predetermined complexation conditions, the 
polyplexes (20 µ L for 1 µ g pDNA) were incubated for 30 min at RT. Complexation ratios of 
polyplexes were calculated by counting the amines (N) of polycations and the phosphate 
groups (P) of pDNA.  
Particle size and surface charge of polyplexes were monitored under different medium pHs to 
understand whether medium pH affects these polyplex characteristics. The polyplex solution 
was added to HBG with different pHs (i.e., pHs 7.4, 7.0, 6.7 and 6.3). The concentration of 
pDNA in the polyplex solution was 2.5 µ g/mL for surface charge measurements and 5 µ g/mL 
for particle size measurements. Surface charge and particle size of polyplexes were measured 
using a Zetasizer 3000HS (Malvern Instrument, Inc., Worcestershire, UK) at a wavelength of 
677 nm with a constant angle of 90o at RT.  
The pH-induced dissociation kinetics of polyplexes under different pH environments were 
evaluated with a dye-dequenching method. PLL/pDNA and PEI/pDNA complexes were 
prepared with YOYO-1-intercalated pDNA (YOYO-1:pDNA = 1 molecules:5 base pair). 
After adding polyplexes (20 µ L; 1 µ g pDNA) into different pH RPMI1640 media (180 µ L; 
adjusted to pHs 7.4, 7.0, 6.7, and 6.3), the fluorescence intensity of YOYO-1 in the 
polyplexes was monitored at 491 nm (excitation) and 509 nm (emission) every 5 min for 4 hr. 
To evaluate the time-dependent fluorescence change of each polyplex exposed to different pH 
media, the relative fluorescence units (RFU) of each polyplex at each pH were measured and 
t=0 was set to 100%. 
 
2.5. In vitro transfection 
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MCF7, MCF7/ADR-RES, and MES-SA cells were used for in vitro transfection studies. As 
reported previously [1, 18, 43], transfections were performed in 6-well plates, and cells were 
seeded at a density of 5×105 cells/well. The seeded cells were cultured for 24 hr prior to 
adding polyplexes. One hour before transfection, the complete culture medium was replaced 
with serum-free and insulin-free medium. After dosing the polyplexes (20 µ L; 1 µ g pDNA), 
the cells were incubated with transfection mixtures for 4 hr, followed by an additional 44 hr 
incubation in complete culture medium. After transfection, the cells were rinsed twice with 
DPBS and then lysed using a reporter lysis buffer. Measurements of relative luminescence 
units (RLU) and protein content of transfected cells were performed per the manufacturer’s 
instructions. 
To investigate the effects of extracellular pH on polymeric transfection, four different pHs, 
pH 7.4, 7.0, 6.7, and 6.3, were used. Transfection procedures were separated into two periods 
(i.e., the 4 hr transfection period and 44 hr incubation period) as follows: 
Condition A: 4-hr transfection period at different pHs (pH 7.4, 7.0, 6.7, and 6.3) followed by 
the 44-hr incubation period fixed at pH 7.4. 
Condition B: 4-hr transfection period at pH 7.4 followed by the 44-hr incubation period at 
different pHs (pH 7.4, 7.0, 6.7, and 6.3). 
Condition AB: 48-hr transfection period and incubation period both at different pHs (7.4, 7.0, 
6.7, and 6.3). 
 
2.6. In vitro metabolic activity 
The MTT-based metabolic activity of polyplex-transfected cells was assessed using MCF7, 
MCF7/ADR-RES, and MES-SA cells. Cells were seeded in 12-well plates at a density of 
2.5×105 cells/well and cultured for 24 hr prior to polyplex addition. The experimental 
procedure was the same as previously described for in vitro transfection except for the 
polyplex loading dose (10 µ L; 0.5 µ g pDNA). After the 48-hr transfection procedure, MTT 
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solution (0.1 mL; 5 mg/mL) was added to the cells in 1 mL of culture medium. After 4 hr, the 
MTT-containing medium was removed. Living cells produced formazan crystals that were 
dissolved in DMSO; crystal absorbance was measured at 570 nm with a microplate reader. 
 
2.7. Cellular uptake of polyplexes 
As previously described for in vitro transfection, cells were prepared in 6-well plates. 
Polyplexes (20 µ L; 1 µ g pDNA) prepared using YOYO-1-intercalated pDNA were added to 
the cells. After a 4-hr incubation under 4 different pH environments (pH 7.4, 7.0, 6.7, and 
6.3), the cells were detached and then fixed using 4% PFA solution. The cells containing 
fluorescent polyplexes were monitored using flow cytometry (FACScan Anaylzer, Becton- 
Dickinson, Franklin Lakes, NJ) with a primary argon laser (488 nm) and fluorescence detector 
(530±15 nm) for YOYO-1. Polyplex uptake was analyzed using a gated population containing 
at least 5,000 cells. 
 
2.8. Cell cycle phases 
The cell-cycle phases of MCF7, MCF7/ADR-RES, and MES-SA cells incubated in different 
pH media were assessed. Cells were seeded in 6-well plates at a density of 5×105 cells/well 
and cultured for 24 hr prior to treatment with different pH media. Then, cells were exposed to 
4 different pH transfection media (i.e., pH 7.4, 7.0, 6.7 and 6.3) for 4 hr and then 4 different 
pH culture media (i.e., pH 7.4, 7.0, 6.7 and 6.3) for 44 hr. During the transfection process, 
cells were sampled at predetermined time points (i.e., 0, 2, 4, 12, 24, 36, and 48 hr post-
transfection). The cells were rinsed twice with DPBS and detached with trypsin-EDTA 
solution. The rinsed and suspended cells were fixed with cold 70% (v/v) ethanol (aq.). Fixed 
samples were rinsed twice with DPBS and incubated with 1 mL of a PI-containing DPBS 
solution (50 µ g/mL PI, 0.1% Triton®X-100 solution, and 15 µ g/mL RNase) for 30 min at RT. 
The stained samples were analyzed by flow cytometry with a primary argon laser (488 nm) 
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and fluorescence detector (668 nm long pass); at least 15,000 cells were counted per 
condition. 
 
2.9. Intracellular pH measurement of polyplexes 
The intracellular pH environment of polyplexes was monitored using fluorescent dye labeled 
polymers as previously reported [43]. PLL and PEI were labeled with pH-sensitive FITC and 
pH-insensitive RITC dyes using a simple coupling reaction. PLL and PEI were each labelled 
with both FITC and RITC, creating FITC-PLL-RITC (2.3 mol% (based on Llysine units) 
FITC; 1.2 mol% RITC), and FITC-PEI-RITC (1.6 mol% (based on amines) FITC; 0.4 mol% 
RITC), respectively [43]. 
As previously described for in vitro transfections [43], cells were prepared in 6-well plates. 
Polyplexes (20 µ L; 1 µ g pDNA) were prepared using FITC-PLL-RITC or FITC-PEI-RITC, 
and added to cells. At predetermined time points (i.e., 0.5, 1, 1.5, 2, 3, and 4 hr 
posttransfection), the cells were detached and then resuspended in DPBS 1% PFA solution. 
To create a pH calibration curve, the transfected cells were resuspended in 0.5 mL of pH 
clamp buffers (approximately pH 7.4, 6.8., 6.0, 5.0, and 4.0) that were prepared by mixing 
DPBS (pH 7.4) or MES (pH 4.0; 50 mM MES, 150 mM NaCl, 4 mM KCl, and 1 mM 
MgSO4). 
Monensin (20 µ M) and nigericin (10 µ M) were added into pH clamp buffers to ensure 
homogeneity of the pH environment for cells. The cells harboring fluorescent polyplexes were 
monitored using flow cytometry (FACScan Anaylzer, Becton-Dickinson) with a primary 
argon laser (488 nm) and fluorescence detectors (530±15 nm for FITC and 585±21 nm for 
RITC). The average intracellular pH of polyplexes was assessed by analyzing the ratio of 
FITC to RITC intensity from a gated population of at least 5,000 cells. In order to identify and 
assign the major intracellular compartments holding the polyplexes from the intracellular pH, 
the entire fluorescent cell population was divided into four areas based on the cellular pH 
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calibration curve. The nucleus, and potentially the cytoplasm, was designated by pH values 
greater than pH 6.8, early endosomes were approximated between pH 6.0 and pH 6.8, late 
endosomes were between pH 5.0 and pH 6.0, and lysosomes were classified with a pH less 
than 5.0 [43]. 
 
3. Results and discussion 
Prior to applying extracellular media of various pH values (i.e., culture medium and 
transfection medium) for in vitro polymeric transfection, the optimum conditions for PEI- and 
PLL-based transfection of MCF7, MCF7/ADR-RES, and MES-SA cells were determined 
using less toxic polymer/pDNA complexation ratios. For PEI/pDNA complexes, N/P 5 was 
applied to all cell lines used in this study because, in general, higher N/P values cause 
cytotoxicity [19, 22, 44]. For PLL/pDNA complexes, N/P 5 was used for MCF7 and 
MCF7/ADR-RES cells based on our previous report [43]. For MES-SA cells, N/P 10 was 
used as the optimum transfection condition based on results from a test of N/P values between 
3 and 15 (Fig. S1). 
 
3.1. Effects of extracellular pH on transfection efficiency 
PEI- and PLL-mediated transfection efficiencies are shown in Fig. 1 for cells exposed to 
specific extracellular pHs. Luciferase expression of the cells transfected with 4 different 
medium pHs (i.e., transfection medium and culture medium) for 48 hr (Condition AB) was 
polyplex- and cell-dependent. The medium pH strongly influenced transgene expression of 
PEI/pDNA-transfected MCF7, MCF7/ADR-RES, and MES-SA cells (p<0.001, p<0.001, and 
p=0.004 by one-way ANOVA, respectively). Using pH 7.4 medium, PEI/pDNA-transfected 
MCF7 cells had approximately 2-fold to 3-fold higher transfection efficiency than those at pH 
7.0, 6.7, and 6.3 (p=0.01, p=0.02, and p=0.09 by one-way ANOVA with Tukey HSD test, 
respectively). Interestingly, PEI/pDNA-transfected MCF7/ADR-RES and MES-SA cells 
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showed increased transgene expression with decreasing medium pH values. Specifically, gene 
expression in medium pH 6.3 was approximately 2-fold higher than in medium pH 7.4 
(p<0.001 for MCF7/ADR-RES cells and p=0.01 MES-SA cells by one-way ANOVA with 
Tukey HSD test).  
PLL/pDNA-transfected cells experienced approximately 2-fold lower (for MES-SA cells) or 
higher (for MCF7 and MCF7/ADR-RES cells) gene expression with medium pH 7.4 than 
medium pH 6.3. However, PLL-mediated transfections were less sensitive to medium pH 
(p=0.27 for MCF7, p=0.07 for MCF7/ADR-RES, and p<0.05 for MES-SA cells by one-way 
ANOVA) than PEI-mediated transfections. Also, transfection results conducted at medium 
pH 7.4 and medium pH 6.3 showed less significant differences (p=0.03 for MES-SA, p=0.21 
for MCF7, and p=0.06 for MCF7/ADR-RES cells by one-way ANOVA with Tukey HSD 
test) for PLL versus PEI. These medium pH-induced polymeric transfection results were 
further analyzed to understand which steps of polymeric transfection are strongly affected by 
the extracellular pH. Thus, pH-controlled medium treatment was divided into transfection 
medium for 4-hr transfection periods and culture medium for 44-hr incubation periods. When 
applying Condition A (transfection media of various pHs) as shown in Fig. 1, acidic 
transfection media caused either decreased or nearly equal transfection efficiencies compared 
with neutral transfection medium. For PEI/pDNA-transfected MCF7 and MCF7/ADR-RES 
cells, transfection medium pH 6.3 reduced transfection efficiency by as low as 7.7-fold and 
2.1-fold, respectively, compared with transfection medium pH 7.4 (for both, p=0.004 by one-
way ANOVA with Tukey HSD test). Acidic transfection medium (pH 6.3) also caused 
approximately 25-35% reduced transgene expression of MES-SA cells compared to 
transfection medium pH 7.4, although transfection efficiency was less affected by medium pH 
(p=0.23 by one-way ANOVA). PLL-mediated transfections were also influenced by 
transfection medium pH (p=0.04 for MCF7, p=0.02 for MCF7/ADR-RES, and p<0.001 for 
MES-SA by one-way ANOVA). MCF7/ADR-RES and MES-SA cells transfected with 
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transfection medium pH 6.3 had 2.4- fold and 2.7-fold lower transfection efficiencies than 
those with transfection medium pH 7.4 (p<0.05 and p=0.001 by one-way ANOVA with 
Tukey HSD test, respectively). For PLL/pDNA-transfected MCF7 cells, transfection medium 
pH 7.0 caused the highest transfection efficiency, which was approximately 2-fold higher than 
those from other pH transfection media. However, unlike the pH effects of transfection media, 
transfection efficiencies increased in acidic culture media (called as Condition B) (Fig. 1). 
The pH of the culture medium significantly influenced transfection efficiencies for 
PEI/pDNA-transfected MCF7/ADR-RES and MES-SA cells (for both, p<0.001 by one-way 
ANOVA), and their transfection efficiencies in culture medium pH 6.3 were 1.9-fold and 2.6-
fold higher than those in culture medium pH 7.4 (for both, p<0.001 by one-way ANOVA with 
Tukey HSD test). For PEI/pDNA-transfected MCF7 cells, although the effect of culture 
medium pH on PEImediated transfection efficiency was not statistically significant (p=0.31 
by one-way ANOVA), transfection efficiencies using culture medium pH 6.3 were 1.6-fold 
higher than those at culture medium pH 7.4 (p=0.49 by one-way ANOVA with Tukey HSD 
test). When transfecting cells with PLL/pDNA using Condition B, there was no statistically 
significant influence of decreased culture medium pH values on transfection efficiencies 
(p=0.22 for MCF7, p=0.28 for MCF7/ADR-RES, and p=0.30 for MES-SA cells by one-way 
ANOVA). However, the culture medium pH 6.3 induced approximately 1.6-fold higher 
transfection efficiencies for PLL/pDNA-transfected MCF7 and MCF7/ADR-RES cells than 
culture medium pH 7.4 (p=0.33 and p=0.34 by one-way ANOVA with Tukey HSD test, 
respectively). 
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3.2. Effects of extracellular pH on MTT-based cellular activity  
MTT-based cellular activity assays were applied to understand how the extracellular pH 
influences cell number, cell viability, metabolic activity, and the cell proliferation rate of 
polyplex-transfected cells. When different medium pHs were applied to untransfected cells 
(Condition AB), the cellular activities significantly decreased with decreasing pHs, regardless 
of cell type (for all cell lines, p<0.001 by one-way ANOVA) as shown in Fig. 2. These results 
are consistent with previous studies [35, 45]. However, regardless of the type of polyplex 
used, the cellular activity of most transfected cells was almost the same as untransfected cells 
at the same pH. In Fig. 2, 4-hr treatment of acidic transfection media (Condition A) did not 
significantly damage the cellular activities of untransfected or transfected cells versus neutral 
transfection media treatment. On the other hand, longer treatment (44 hr) of acidic medium 
(Condition B) induced similar cellular activities to Condition AB treatment. However, it is not 
clear whether acidic medium caused reduced cell viability and/or metabolic activity or 
inhibited cell proliferation (without cell death). 
 
3.3. Effects of medium pH on polymers and polyplexes 
When polymers and polyplexes are exposed to different pH environments, their chemical, 
physical and electrochemical properties can be changed. First, the proton buffering capacity 
of PEI and PLL were monitored by acidic titration. As shown in Fig. S2, a PLL solution had 
no proton buffering capacity like a NaCl aqueous solution (150 mM) because the primary 
amines of PLL stay protonated within the range of basic to acidic pHs. On the contrary, a PEI 
solution exhibited proton buffering throughout a broad pH range (approximately pH 3-10) due 
to continuous protonation of primary, secondary, and tertiary amines upon acidification. 
These results are consistent with previous reports [46]. During acidification, protonation of 
amines increases the net positive charge character, and the altered charge could affect 
electrostatic interactions between polymers and pDNA. In this way, medium pH (i.e., buffer 
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pH) could influence complexation and decomplexation between polymers and pDNA as well 
as particle size and surface charge of polyplex. Nevertheless, Godbey et al., reported that PEI-
mediated transfection efficiencies were not different when PEI/pDNA complexes were 
prepared in different pH solutions [47]. Thus, this study excluded the effects of medium pH 
on complexation. All polyplexes were prepared at pH 7.4.  
When polyplexes were exposed to different medium pHs, the changes of PEI/pDNA and 
PLL/pDNA complexes’ particle size, surface charge, and decomplexation were investigated. 
As expected, the particle size and surface charge of PLL/pDNA complexes were not affected 
by HBG with different pHs (p=0.88 and p=0.96 by one-way ANOVA, respectively) (Fig. 3(a) 
and 3(b)). These results may be attributed to unaltered primary amine protonation of PLL 
within the pH range of 6.3 to 7.4; the side chain of L-lysine has pKa 8.95. In the case of 
PEI/pDNA complexes (Fig. 3(a) and 3(b)), particle sizes were around 80-90 nm in solutions 
pH 6.7-7.4, although the size at pH 6.3 (106±19 nm) was somewhat increased compared to 
those at other pHs. Surface charges ranged between 10-15 mV without statistical significance 
related to pH effects. 
The effects of medium pH on decomplexation were monitored over time as shown in Fig. 
3(c). Medium pH 7.4 resulted in increased decomplexation (i.e., increased fluorescent   
intensity) with time, regardless of polyplex type. However, acidic medium (pH 6.3 to 7.0) 
compared to medium pH 7.4 showed decreasing or constant fluorescent intensity over time. 
These results may be caused by increasing (+/-) charge ratios of polyplexes because the 
phosphate groups of pDNA (approximately pKa 6.3) are less negatively charged at acidic pH 
than pH 7.4. This phenomenon may be similar to tight complexation of polyplexes at high 
(+/-) charge ratios. 
Our findings suggest that polyplexes may be stable in acidic extracellular environments and 
during endosomal acidification, but could be dissociated in neutral pH environments such as 
the cytoplasm or the nucleus. If medium pH 7.4 can induce a weak attraction between 
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polycations and pDNA in polyplexes within 4 hr, before cellular internalization, this may 
facilitate pDNA release from polyplexes after endosomal release, thereby enhancing 
polymeric transfection efficiency. That is, high pH-induced decomplexation could generate 
higher transfection efficiency than low pH-induced decomplexation. 
 
 
3.4. Effects of medium pHs on polyplex uptake 
In transfection experiments, transfection medium was applied for 4 hr and then replaced with 
culture medium. At 4 hr post-transfection, the polyplexes that were not endocytosed will be 
removed. Thus, only internalized polyplexes will be available for gene expression. During the 
first 4 hr post-transfection, the different pHs of transfection medium for Conditions AB and A 
could affect cellular polyplex uptake, whereas the same pH of transfection medium under 
Condition B could cause the same cellular uptake. 
Thus, when different medium pHs were applied, cellular uptake 4 hr post-transfection was 
monitored by flow cytometry. As shown in Fig. S3, PEI/pDNA uptake in MCF7 cells in 
transfection medium pH 7.4 was somewhat lower than uptake under other transfection 
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medium pHs. A similar amount of PLL/pDNA complexes was internalized into transfected 
MCF7 cells regardless of the transfection medium pH. However, MCF7/ADR-RES and 
MES-SA cells showed negligible effects of altered transfection medium pH for PEI/pDNA 
and PLL/pDNA uptake. 
 
3.5. Effects of medium pH on cell cycle phases  
The cell-cycle phase of transfected cells affects cellular internalization, endocytosis, and 
transfection efficiency of gene complexes [48-51]. Cellular internalization of nonviral gene 
complexes during the G2/M phases was 1.5-fold lower than during late G1 [51]. Polymeric 
transfection initiated at the S or G2/M phases caused approximately 30-fold or more than 500- 
fold higher transgene expression than transfections beginning at G1, respectively [48]. Thus, 
we monitored the effect of medium pH on cell cycle phases. During the first 4 hr 
posttransfection, the G1, S, and G2 phases of cells from different medium pHs were not 
significantly different (Fig. S4). This may support the similar cellular internalization of 
polyplexes shown in Fig. S3. Under Condition A, the effects of different tranfection pHs on 
polymeric transfection efficiency may be caused by other effectors, but not the cell-cycle 
phase. 
However, after the first 4 hr post-transfection, cell-cycle phases were indeed influenced by 
medium pH. Even though the impact of acidic medium is cell-dependent, the medium at pH 
6.3 induced more G1 phase and less S and G2 phases than other pHs, regardless of the cell 
type (Fig. 4). In MCF7 cells, medium at pH 6.3 slightly inhibited cellular functions such as 
cell proliferation (G2 phase) and DNA duplication (S phase) compared with other medium 
pHs. Compared to MCF7 cells, MCF7/ADR-RES and MES-SA cells were strongly 
influenced by medium pH. In the case of MCF7/ADR-RES cells, medium at pH 6.7, 7.0 and 
7.4 did not show any significant changes on cell cycle phases within the first 12 hr 
posttransfection.  
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However, acidic (pH 6.3) medium-treated MCF7/ADR-RES cells had remarkably increased 
G1 phases and reduced S and G2 phases 24 hr post-transfection, unlike treatment with the 
other pH media. For MES-SA cells, acidic medium clearly showed higher G1 phases and 
lower S and G2 phases than neutral medium 4 hr post-transfection. These findings indicate 
that the cytoskeletal network for endocytosis of polyplexes may be maintained. Also, the 
lower proportion of mitotic cells in acidic medium could prevent dilution of gene expression 
per cell so long as the acidic medium does not damage cell viability. These two possibilities 
indicate that acidic culture media induces better transgene expression than neutral culture 
media under Condition B.  
 
 
3.6. Intracellular environment of polyplexes 
The intracellular location and pH of polyplexes or pDNA strongly affect polymeric 
transfection efficiency [43, 52]. Thus, we estimated how the medium pH influences the 
intracellular environment of polyplexes using flow cytometry as previously reported [43]. In 
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cells transfected with PEI/pDNA and PLL/pDNA complexes, the average intracellular pH 
environment was monitored during the first 4 hr post-transfection (Fig. 5). Polyplexes 
continuously internalize until they are used up from the extracellular medium. Therefore, 
polyplexes could be exposed to different subcellular locations, and the transfected cells 
having these polyplexes may experience different intracellular pHs over time. Thus, as shown 
in Fig. 6 and Fig. 7, it was estimated how many polyplex-transfected cells had average 
intracellular pHs conducted from polyplexes exposed to the pH of subcellular compartments 
(e.g., the cytosol, the early and late endosomes, the lysosomes, and the nucleus) over time. As 
shown in Fig. 5, the effects of transfection medium pH on the average intracellular pH of 
polyplex-transfected cells were cell- and polyplex-dependent. The average intracellular pH of 
PLL-mediated MCF7 transfected cells was not significantly influenced by the medium pH, 
whereas the intracellular pH for MCF7/ADR-RES and MES-SA transfections was affected by 
medium pH. In PLL/pDNA-transfected MCF7/ADR-RES cells, acidic medium induced a 
slow drop in intracellular pH within the first 2 hr post-transfection. Recovery of intracellular 
pH, which was caused by endosomal escape of polyplexes [43], was somewhat lower 
(approximately 0.1~0.2 pH units). Furthermore, the time points for intracellular pH recovery 
were delayed (2 hr post-transfection for medium pH 6.3 vs. 0.5-1 hr post-transfection for 
medium pH 7.4). Similarly, MES-SA cells transfected with PLL/pDNA complexes showed an 
acidic medium (pH 6.3)-mediated slow intracellular pH recovery (1.5 hr post-transfection vs. 
0.5-1 hr post-transfection at medium pH 7.4) and low recovered intracellular pH (~ pH 6.5 vs. 
pH 6.7 at medium pH 7.4). These results are probably not attributed to polymer characteristics 
because PLL does not have proton buffering capacity in the pH range experienced during 
intracellular polyplex trafficking. One significant contribution could be the acidic medium-
induced changes to cell characteristics; acidic extracellular medium lowered intracellular 
(cytoplasmic) pHs [37], and acidic cytosolic pHs are known to inhibit/delay the endocytosis 
of therapeutics such as proteins [38, 53-55]. 
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Delayed endosomal acidification rates and lower intracellular recovery pHs of PLL/pDNA-
transfected cells in acidic medium could be supported by the population data of cells with 
average intracellular pHs related to subcellular compartments. As shown in Fig. 6, it seems 
that medium pH does not significantly affect time-dependent polyplex uptake (column plots) 
or the average intracellular pH (dot plots) relevant to subcellular compartments. Regardless of 
the medium pH, PLL/pDNA-transfected MCF7 cells had an average intracellular pH between 
pH 7.25-7.35 (relevant to the cytosol/the nucleus), pH 6.55- 6.70 (relevant to the early 
endosomes), pH 5.40-5.55 (relevant to the late endosomes), and ~ pH 4 (relevant to the 
lysosomes). The pH ranges of PLL/pDNA-transfected MCF7/ADR-RES cells were pH 7.01-
7.13, pH 6.18-6.47, pH 5.40-5.57, and pH 4.00-4.10, and were lower than those of MCF7 
transfected cells due to the fast endosomal acidification rates of MDR cells [43]. Also, 
PLL/pDNA-transfected MES-SA cells had pH 7.17-7.27, pH 6.44-6.64, pH 5.48- 5.65, and 
pH 4.00-4.15. However, in PLL/pDNA-transfected MCF7/ADR-RES cells and MES-SA 
cells, the peak cell populations relevant to late endosomes and lysosomes (from column plots 
of Fig. 6) were delayed with acidic medium treatment. This acid mediuminduced delayed 
acidification process could cause delayed cytosolic release of polyplexes. Also, the lower 
intracellular pH may slow down decomplexation rates. Together, these phenomena may 
influence the acidic transfection medium-induced decrease in polymeric transfection 
efficiency. When applying PEI/pDNA complexes (having endosomal disruption capability) to 
the cells, the intracellular pH of transfected cells was higher (> ~pH 6.7) than those of 
PLL/pDNA-transfected cells (Fig. 5) because the proton buffering capacity of PEI can break 
endosomal membranes, quickly releasing PEI/pDNA into the cytoplasm. Like 
PLL/pDNAtransfected cells, PEI/pDNA-transfected cells were influenced by delayed 
endocytosis and endosomal acidification of polyplex-trapped endosomes when treated with 
acidic transfection medium. This was clearly demonstrated by the fast endosomal 
acidification rates (e.g., MCF7/ADR-RES cells in this study). As shown in Fig. 7, transfection 
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medium pH 6.3 caused more cells to be exposed to early endosomal pHs than transfection 
medium pH 7.4. Also, the delayed endosomal acidification may negatively influence the 
endosomal release of PEI/pDNA complexes because the proton buffering capacity of PEI is 
strongly affected by decreasing pH. 
Based on the transfection results of Conditions AB, A, and B (as summarized in Table 1), 
acidic transfection media decreased polymeric transfection efficiencies, whereas acidic 
culture media enhanced efficiencies. The effects of transfection media on transfection 
efficiency may be mediated by the delayed acidification rates of polyplex-trapped 
endolysosomes and the decomplexation rates during the transfection period. Delayed 
endosomal acidification caused by acidic transfection media resulted in delayed cytosolic 
release of polyplexes (i.e., sequestrated in the late endosomes and lysosomes). In addition, 
polyplexes in acidic extracellular environments and slightly acidic cytosol could be tightened 
and then slowly release pDNA. These reasons might explain why acidic transfection media 
decreased polymeric transfection efficiencies. 
On the other hand, the culture medium affected the cell cycle phase and metabolic activity of 
transfected cells. Under acidic conditions, the metabolic activity of transfected cells was 
reduced. Although these results may have been caused by a reduction in viable cells, the 
metabolic functions of transfected cells could be limited by cellular arrest (i.e., increased G1 
phase and decreased G2 and S phases) without cell death. Cellular arrest could delay mitosis, 
leading to less dilution of gene expression in transfected cells. As a result, acidic culture 
medium can enhance polymeric transfection efficiencies. Thus, the impact of transfection 
media and culture media on cells may determine the effects of medium pH on transfection 
efficiency. Nevertheless, in regard to the effects of extracellular pH on polymeric transfection, 
the pH of the culture medium could be more influential than the pH of the transfection 
medium because transfected cells are exposed to culture medium longer (44 hr) than 
transfection medium (4 hr). The findings in this study may be helpful for developing effective 
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polymeric vectors for solid tumors and ischemia because these cells pathologically feature 
acidic extracellular environments. 
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4. Conclusion 
In vitro polymeric transfection was strongly affected by the extracellular pH. Transfection 
media modulated both polymer/polyplex characteristics (e.g., proton buffering and 
decomplexation) and cellular characteristics (e.g., endocytic trafficking), whereas culture 
medium affected only cellular characteristics (e.g., cell proliferation, cell cycle phase, and 
mitosis). In conclusion, acidic transfection medium reduced and acidic culture medium 
enhanced polymeric transfection efficiency. When treating with a specific extracellular pH 
during polymeric transfection, the impact of transfection medium and culture medium may 
determine the effect of medium pH on transfection efficiency.  
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2.1. ABSTRACT 
A library of mono-methoxyl-poly(ethylene glycol)-block-poly(ε-caprolactone) (mPEG-PCL) 
modified hyperbranched PEI copolymers (hy-PEI-PCL-mPEG) was synthesized to establish 
structure function relationships for siRNA delivery. These amphiphilic block-copolymers 
were thought to provide improved colloidal stability and endosomal escape of polyplexes 
containing siRNA. The influence of the mPEG chain length, PCL segment length, hy-PEI 
molecular weight and the graft density on their biophysical properties was investigated. In 
particular, buffer capacity, complex formation constants, gene condensation, polyplex 
stability, polyplex size and zeta-potential were measured. It was found that longer mPEG 
chains, longer PCL segments and higher graft density beneficially affected the stability and 
formation of polyplexes and reduced the zeta-potential of siRNA polyplexes. Significant 
siRNA mediated knockdown was observed for hy-PEI25k-(PCL900-mPEG2k)1 at N/P 20 
and 30, implying that the PCL hydrophobic segment played a very important role in siRNA 
transfection. These gene delivery systems merit further investigation under in vivo conditions. 
 
2.2. INTRODUCTION 
Gene silencing by short interfering RNA (siRNA) offers tremendous promise for the 
treatment of many genetic and acquired diseases. The discovery of siRNA in mammalian cells 
[1] provides a new and much more effective strategy to induce the degradation of specific 
mRNA sequences that may regulate diseased cells [2]. Similar to plasmid DNA (p-DNA), 
siRNA also consists of double-stranded nucleic acids. They possess a phosphodiester 
backbone with the same negative charge to nucleotide ratio, and can interact electrostatically 
with cationic agents [3]. The duration of siRNA therapeutic effects was reported to be longer 
than that of p-DNA [4]. Additionally, siRNA needs to be delivered to the cytosol only [5]. 
The development of safe and efficient non-viral carriers for siRNA remains a challenging 
task. Among the vast family of non-viral gene delivery systems, poly (ethylenimine) (PEI) 
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and its derivatives have taken a prominent position due to their high positive charge density. 
They are able to effectively condense nucleic acids into homogenous polyplexes with sizes of 
 100 nm, which are capable of transfecting cells efficiently in vitro as well as in vivo [6]. 
Recent reports showed that PEI can facilitate efficient delivery of siRNA both in vitro and in 
vivo [7]. The molecularweight of PEI was a critical factor influencing the toxicity and 
transfection efficiency [8]. PEI with higher molecular weight, for example, 25 kDa, exhibited 
both higher transfection efficiency and higher toxicity than other smaller PEIs [9, 10]. The 
dilemma of the correlation of toxicity with transfection efficiency has been the key obstacle 
for the application of PEI in vivo. Many strategies to overcome these problems have been 
proposed. For instance, the introduction of hydrophilic and hydrophobic segments in PEI 
molecules [11–13], the cross-linking of small PEI molecules via disulfide bonds [14] or ester 
bonds and/ or amide-based PEI derivatives [15, 16], the modification of polyplexes' surface to 
shield the positive charge [17], and the conjugation of PEI with ligands [18]. Amphiphilic 
polymer structures containing mPEG as the hydrophilic component and PCL as flexible 
hydrophobic segments grafted onto branched PEI (hy-PEI) molecules could hypothetically 
form micelles exhibiting a core-corona structure. These carriers could improve the solubility 
and colloidal stability of polyplexes in aqueous solution and biological fluids. Also 
transfection efficiency could be improved due to facilitated transmembrane transport [19, 20]. 
Moreover, the core corona arrangement could offer the possibility of multi-functionality [21] 
whereby the co-delivery of siRNA (corona) and hydrophobic markers or drugs (core) could be 
envisaged. Previous results demonstrated that this strategy could be promising. The 
cytotoxicity decreased with increasingmolecularweights of the PCL and mPEG segments. Hy-
PEI-PCL-mPEG with very short PCL segments displayed higher transfection efficiency 
compared to hy-PEI25k. The hy-PEI-PCL-mPEG copolymers also exhibited the cleavage of 
ester bonds in aqueous solution [20, 22]. Despite these initial results knowledge about 
relationships between the copolymer structure and function as a gene delivery vector is still 
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limited. To demonstrate that these copolymers can be used for efficient siRNA delivery, 
further investigations were required. We hypothesized that hy-PEI-PCL-mPEG might show 
controllable stability of polyplexes, and transfection properties for siRNA as a function of 
different polymer compositions. Hence a library of hy-PEI-PCL-mPEG copolymers with 
varying mPEG length, short PCL segments, graft density and two molecular weights of hy-
PEI (10 kDa and 25 kDa) was synthesized to explore the influence of polymer compositions 
on the physicochemical properties of the polymers as well as the relationship to efficiency of 
siRNA transfection to enable successful application of this type of polymer for siRNA 
delivery in the future. 
 
 
2.3. MATERIALS AND METHODS 
 
2.3.1. Materials 
Poly(ethylene glycol)-mono-methyl-ether (mPEG) (MW, 550 Da, 2 kDa, 5 kDa) and 
caprolactone were purchased from Fluka (Taufkirchen, Germany). Acryloyl chloride and tin 
(II) 2-ethylhexanoate (SnOct2) were from Sigma-Aldrich (Taufkirchen, Germany). Hy-PEIs 
with molecular weights of 25 kDa (hy-PEI25k) and 10 kDa (hy-PEI10k) were obtained from 
BASF (Ludwigshafen, Germany) and Polysciences Inc. (Eppelheim, Germany) respectively. 
2´-O-Methylated 25/27mer DsiRNA targeting Firefly Luciferase and a Non-Coding control 
DsiRNA were obtained from Integrated DNA Technologies (Leuven, Belgium). Other 
reagents of analytical quality were used without further purification. As abbreviations hy 
PEIα, PCLβ, mPEGγ, mPEGγ-PCLβ and hy-PEIα-(PCLβ-mPEGγ)n were used. Herein n 
represents the graft density of mPEG-PCL on PEI while α, β and γ describe the molecular 
weight of PEI, PCL and mPEG segments, respectively. 
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2.3.2. Synthesis and characterization 
Hy-PEI-PCL-mPEG was synthesized as described previously [20]. Briefly, mPEG, ε 
caprolactone and SnOct2 were reacted in a roundbottom flask at 120 °C under stirring for 24 
h. One mmol of dried products was mixed with 2 mmol of triethylamine and 2 mmol of 
acryloyl chloride in 40 ml of toluene and stirred for 8 h at 80 °C, followed by the removal of 
triethylamine hydrochloride and precipitation of the polymer by addition of cold n-hexane. 
The dried precipitate (based on the molar ratio of hy-PEI) was finally reacted with PEI in 
chloroform at 45 °C for 8–24 h (higher graft density required longer reaction time). The 
copolymer was characterized by 1H NMR and 13C NMR spectroscopy, which verified its 
structure and enabled calculation of its composition. Gel permeation chromatography (GPC) 
demonstrated the absence of unreacted mPEG-PCL diblock copolymer and PEI 
homopolymers. No further purification steps were necessary. Details of the characterization 
are shown in Table 1 of the supplementary materials. 
 
2.3.3. Buffer capacity of hyPEI-PCL-mPEG  
1 ml of polymer aqueous solution at the concentration of 0.01 and 0.05 M (based on the repeat 
unit of PEI) was titrated by aliquots of standard 0.1 M HCl at each time point and the pH 
response was monitored at room temperature [23] by a Hanna bench top pH meter 210 
(Hanna Instrument, Germany) fitted with a microelectrode Model 421 (Inlab, Mettler Toledo, 
Schwerzenbach, Switzerland). The titration was stopped at pH 2. All samples were titrated in  
triplicate. The buffer capacity (β) was calculated from the titration curves as reported earlier, 
β=dCHCl/dpH [24, 25]. The individual amino group of the copolymers was considered as a 
mono-protic base B. So pKa=pH+log([BH+]/[B]). The concentration fractions of [B] and 
[BH+] in the copolymer solution were defined as [23, 24]  
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Here, α1 and α0 represent the percentage of protonated and unprotonated nitrogen atoms 
respectively. 
 
2.3.4. Complex stability of copolymers 
The complex stability of copolymers was described by the complex formation constant (K), 
which was calculated as follows: K=[Cu-PEI]/[Cu] [PEI] [24], where, [Cu-PEI] stands for the 
concentration of copper and PEI bound in the complex. Titration was performed with 0.1 M 
copper sulfate as titrant [26]. All solutions used in this assay were prepared in 5% potassium 
acetate at pH 5.5. Copper sulfate solution was added to the polymer solution (1 mg/ml), and 
the optical density at 285 nm was recorded by an Ultrospec 3000 UV/visible 
spectrophotometer (GE Healthcare, Germany). To quantify the amount of PEI in copolymers, 
a standard titration curve was used. All samples were titrated in triplicate. 
 
2.3.5. Preparation of polyplexes 
Distilled water, PBS buffer (pH 7.4, 0.15 M), 5% glucose, HBG buffer (pH 7.4, 10 mM), and 
sodium acetate solution (pH 5.0, 0.10 M) were selected as media for polyplex preparation. All 
buffer solutions were filtered through 0.20 µm pore-size filters (Nalgene syringe filter, Sigma-
Aldrich, Taufkirchen, Germany) before use. Ten µl of stock copolymer solution (1 mg/ml 
based on hy-PEI) were diluted with buffers to a final volume of 50 µl in microcentrifuge 
tubes. siRNA stock solution was also diluted in the same buffers used for copolymers to a 
final volume of 50 µl. Equal volumes of siRNA aliquots and the diluted copolymer solutions 
were mixed by pipetting and incubated for 20 minutes for complex formation. 
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2.3.6. Characterization of polyplexes  
The particle size and zeta-potential of the polyplexes were monitored using a Malvern 
Zetasizer Nano ZS (Malvern Instrument, Herrenberg, Germany) as described previously [22]. 
The size of the polyplexes was measured in a disposable low volume cuvette (100 µl, Uvette, 
Eppendorf, Wesseling–Berzdorf, Germany). Zeta-potential measurements were then carried 
out in the standard clear capillary electrophoresis cell (Malvern, Herrenberg, Germany) at 25 
°C by diluting 100 µl of polyplexes solution with an additional 600 µl of buffer to give a final 
siRNA concentration of 11 ng/µl. The salt stability was determined by the size changes of the 
polyplexes after incremental amounts of 3 M NaCl solution were added stepwise to the 
polyplex solution with vortexing. The total salt concentration required for aggregation of the 
polyplexes was recorded. All experiments were performed in triplicate. 
 
2.3.7. Ethidium bromide complexation assay 
The ethidium bromide complexation assay was performed using a PERKIN ELMER 
fluorescence spectrometer LS 50B (PerkinElmer Instruments, Rodgau, Germany) with an 
excitation wavelength of 510 nm (10 nm slit) and an emission wavelength of 590 nm (10 nm 
slit). 4 µg of anti-luc siRNA was mixed with various amounts of polymer in HBG (containing 
5% glucose buffered with 10 mM HEPES) based on the predetermined N/P ratios using 96-
well plates. After incubation for 10 min, 20 µl of ethidium bromide (0.1 mg/ml) in HBG were 
added and incubated with the polyplexes for 10 min in the dark. The fluorescence intensity of 
the solution was recorded. Triplicate samples were investigated and three consecutive 
measurements were performed and the intensity values were averaged and corrected for 
dilution. The results were transformed into relative fluorescence values (Fsample/FDNA). 
 
2.3.8. Cell culture 
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HeLa cells were purchased from Clontech (Saint-Germain-en-Laye, France) and transfected 
with a Luciferase Reporter Vector pTRE2hyg-Luc (Clontech, Saint-Germain-en-Laye, 
France) containing the luciferase reporter gene and a hygromycin resistance gene, as 
previously reported [27]. Stably transfected cells were maintained in DMEM (PAA 
Laboratories, Cölbe, Germany), supplemented with 10% fetal bovine serum (Cytogen, Sinn, 
Germany), in a humidified atmosphere with 5% CO2 at 37 °C. 
 
2.3.9. MTT assay 
HeLa/Luc cells were seeded in 96-well plates at a density of 8000 cells/well and incubated at 
37°C in 5% CO2 for 24 h prior to the treatment of copolymer solutions with the concentration 
range from 0.00029 to 0.5 mg/ml and incubated as described previously [27]. Briefly, medium 
was changed after 24 h. MTT solution was added into fresh serum-free medium and incubated 
for 4 h. Cell viability was determined by measuring the absorbance of enzymatically formed 
formazan at 580 nm with 690 nm background corrections after cell lysis in 200 µl of DMSO. 
Results are given as mean values of a replicate of four. 
 
2.3.10. siRNA transfections 
HeLa/Luc cells, a cell culture model stably expressing Luciferase [27], were seeded at a 
density of 15,000 cells/well in 48-well plates and incubated at 37 °C in 5% CO2 for 24 h prior 
to transfection. Transfection efficiencies of the polymers with various compositions were 
compared to each other and to Lipofectamine™ 2000 (Invitrogen, Karlsruhe, Germany) (LF) 
as a positive control. Cells were treated with polyplexes of 20 pmol of 2´-O-methylated 
25/27mer DsiRNA targeting Firefly Luciferase (Integrated DNA Technologies, Leuven, 
Belgium) or nonspecific control DsiRNA (Integrated DNA Technologies, Leuven, Belgium) 
and polymers at varied N/P in a total volume of 25 µl. Polyplexeswere prepared in 10mM 
HEPES bymixing equal volumes of siRNA and polymer solutions and incubated for 20min 
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before addition to 250 µl full serum containing medium.Mediumwas changed 4 h post 
transfection to 500 µl, and cells were incubated for another 44 h before they were washed 
with PBS buffer, lysed with CCLR (Promega, Mannheim, Germany) and assayed for 
luciferase expression with a 10mM luciferin solution on a BMG LUMIstar OPTIMA 
luminometer plate reader (BMG Labtech, Offenburg, Germany). Results are shown as relative 
mean values (% of untreated cells with full luciferase expression) in replicates of four +/- 
standard deviation. Statistical analysiswas performed using the software Graph Pad Prism5.0 
(Graph Pad Software, La Jolla, USA). 
 
 
2.4. RESULTS AND DISCUSSION 
 
2.4.1. Characterization of copolymers 
A library of hy-PEI-PCL-mPEG copolymers with varying short PCL segments (molecular 
weight of 342, 570, and 900 Da), hydrophilic mPEG (molecular weight of 0.55, 2 and 5 kDa), 
hy-PEI (molecular weight of 10 and 25 kDa) and graft density (1 and 3) was synthesized as 
described previously [20]. The characteristics of the copolymers are listed in Table 1 of the 
supplementary materials. PCL block length was controlled by the feed ratio. The graft 
density, defined as the average number of mPEG-PCL chains per hy-PEI, and the copolymer 
composition could be calculated from the ratio of the peak area in the 1H NMR spectrum 
corresponding to the methyl group of PCL segments at 4.06 ppm or the methyl group of 
mPEG chains at 3.36 ppm to that of the methyl groups at 2.4–3.0 ppm in hy-PEI. The content 
of hy-PEI was also confirmed by copper (II) ion titration [26], which agreed with the data 
calculated from the 1H NMR spectra. The molecular weights of copolymers obtained by GPC 
confirmed those calculated from NMR spectroscopy. These data suggest that the synthesis of 
these copolymers is reproducible and well controlled. The amphiphilic behavior of hy-PEI-
  67 
 
PCL-mPEG was investigated by a comparison of the 1H NMR spectra in D2O and in CDCl3 
(Fig. 1 of supplementary materials). The signals of hydrophobic PCL segments at 1.35, 1.63, 
2.3 and 4.06 ppm all disappeared in deuterated water while the ratios of mPEG and hy-PEI 
signals did not change due to the hydrophobic force of PCL segments as well as the entropy 
reduction. This indicated that the hydrophobic PCL segments were located inside the 
hydrophobic core surrounded by polar hy-PEI and non-polar mPEG, when dispersed in an 
aqueous environment. At a polymer concentration of 100 µg/ml (based on PEI) in HBG we 
measured the particle size of polymer architectures using dynamic light scattering (Fig. 1). 
Particle sizes from copolymers containing hy-PEI10k were significantly larger than those with 
hy-PEI25k due to the lower surface charge densities while increasing the block-length of 
mPEG and PCL length decreased sizes because of the higher flexibility of longer mPEG 
chains [28] and stronger hydrophobic interactions of longer PCL segments [29]. Polymers 
with a higher graft density exhibited larger sizes probably due to lower chain mobility caused 
by the higher graft density [30]. These results were consistent with earlier reports [13, 31]. 
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2.4.2. Buffer capacity 
One prominent advantage of PEI as a gene vector is its buffer capacity, which destabilizes the 
vesicle and releases the polyplexes from endosomes [32]. To evaluate the feasibility of 
modified hy-PEI as a novel gene carrier, the buffer capacity was evaluated by the titration of 
copolymer solutions with 0.1 M HCl. Plateaus associated with this buffer capacity can be 
observed on the titration curves (Fig. 2A). All the copolymers showed a broad buffer capacity 
ranging from pH 4.0 to 9.0. Fig. 2B shows the buffer capacity of copolymers at pH 5.0 
relevant for endosomal escape by the proton sponge effect. The copolymer, hy- PEI25k 
(PCL570-mPEG550)1, displays the highest buffer capacity. Lower molecular weight PEI and 
PCL segments showed the same reduction in buffer capacity as an increase in chain length of 
mPEG. These results are possibly caused by the shielding effect of mPEG and lower charge 
densities of smaller PEI segments. Surprisingly, upon increasing the graft density from 1 to 3, 
the buffer capacity increased, especially for modified hy-PEI25k. As we know, each amino 
group of the copolymers would have a different pKa value. The pKa values calculated in this 
study were only the apparent ionization data, which was the value dependent on pH (Table 2 
of supplementary materials). The pKa of all the copolymers decreased as pH was reduced to 5 
due to the large number of positive centers present on the polymers at lower pH and 
consequently greater electrostatic suppression of protonation of additional amines [33]. Hy 
PEI25k-(PCL570-mPEG550)1 showed more protonated amino groups at pH 5 than hy-
PEI25k-(PCL900-mPEG2k)1 and hy-PEI25k-(PCL342-mPEG5k)3 followed by hy-PEI25k. 
This behaviour suggested that the conformational stability of the hy-PEI-PCL-PEG 
copolymers were crucial for the buffer capacity of these copolymers [25].  
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2.4.3. Complex stability of copolymers 
To further investigate the effect of copolymer composition on the formation of complexes we 
studied the interaction of copper (II) with different hy-PEI-PCL-mPEG copolymers. Addition 
of copper (II) ions to aqueous polymer solutions led to the formation of dark blue 
cuprammonium complexes suitable for colorimetric analysis of PEI [24, 34]. The inflection 
points of the titration curve represent the N/Cu ratio in the complex (supplementary section, 
Fig. 2). Moreover, the N/Cu ratio varied with the structure of the modified PEI due to the 
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different accessibility of nitrogen atoms for complex formation. Therefore the complex 
stability was used to monitor the stability of copolymer/gene polyplexes. Complex stability 
can be described using the complex formation constant (K), which is depicted in Fig. 3 based 
on the calculation method described above. Hy-PEI25k-(PCL900-mPEG2k)1 showed the 
highest complex stability followed by hy-PEI25k-(PCL570-mPEG550)1. These results 
demonstrated the importance of the hydrophobic core and in the stability of the complexes. 
 
 
2.4.4. siRNA binding affinity 
The formation of polyplexes between siRNA and hy-PEI-PCL-mPEG occurs spontaneously 
based on electrostatic interactions and thermodynamic effects. The siRNA binding affinity of 
polymers can be assessed by an ethidium bromide (EB) assay [35]. The interaction of these 
polymers with siRNA was performed in HBG buffer and the results are shown in Fig. 4. All 
copolymers were able to bind siRNA effectively. Above an N/P ratio of 5, all copolymers 
showed significant fluorescence quenching for siRNA. The EB quenching data suggested a 
strong structural effect of the copolymers on nucleic acid-binding. Copolymers with larger hy-
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PEI segments exhibited stronger binding efficiency due to higher cationic charge densities. 
Surprisingly, longer mPEG chains, longer PCL segments and higher graft density enhanced 
the interaction between copolymers and nucleic acids as well. It is well known that PEG 
blocks provide steric protection for nucleic acid/ polymer complexes [36]. The “conventional” 
PEG-grafted cationic copolymers are effectively shielded by PEG, reducing the available 
positive charges of the polymer for complexation [36]. However, in our studies hy-PEI10k-
(PCL570-mPEG550)1, hy-PEI10k-(PCL570- mPEG550)3, hy-PEI25k-(PCL570-mPEG2k)1 
and hy-PEI25k-(PCL570-mPEG2k)1 represented insignificant enhancement of binding, while 
hy-PEI25k-(PCL900-mPEG2k)1, hy-PEI25k-(PCL342-mPEG5k)1 and hy-PEI25k-(PCL342-
mPEG5k)3 revealed a clear enhancement compared with hy-PEI25k. These results suggest 
that hydrophobic PCL segments and mPEG played a significant role in promoting 
complexation. Similar results of enhanced nucleic acid condensation have recently been 
reported for plasmid DNA [12], antisense oligonucleotides [36], as well as siRNA in 
complexation with PEGylated PEIs [37]. It seems that longer mPEG chains and suitable graft 
densities can separate the PEI/nucleic acid core from the mPEG chains, resulting in the 
effective interaction of PEI with the nucleic acid [37]. Furthermore, longer PCL segments 
caused association into small and stable supramolecular nano-carriers driven by hydrophobic 
interactions [24, 28], while higher graft density improved the stability due to a reduction in 
mobility of the chains [30]. Therefore higher degrees of grafting were believed to be 
necessary to achieve efficient nucleic acid condensation compared to unmodified PEI [37]. 
Moreover, only hy-PEI25k-(PCL900-mPEG2k)1 and hy-PEI25k-(PCL342-mPEG5k)3 
exhibited significant affinity over the entire range of N/P ratios tested. This can be explained 
by the rigid rod-like behavior of the shorter siRNA molecules [3]. 
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2.4.5. Characterization and stability of polyplexes (polymer/siRNA complexes) 
The size and zeta-potential of polyplexes were measured at N/P 10 in HBG buffer using 
dynamic laser light scattering (DLS) to investigate the influence of copolymer compositions 
on the characteristics of the polyplexes. Fig. 5A shows difference concerning the polyplex 
sizes of both unmodified and modified hy-PEI10k and hy-PEI25k in HBG buffer. Smaller 
polyplex size was obtained for polyplexes compared with blank micelles (Fig. 1) due to the 
condensation effects of negatively charged nucleic acid. Higher graft density and longer 
mPEG chain length decreased both the size and zeta-potential of polyplexes, which is in line 
with earlier reports [36, 37]. This behavior was attributed to the increased steric hindrance 
associated with the longer PEG blocks, which maximized the space between the hydrophilic 
segments. The polyplexes of hy-PEI25k-(PCL900-mPEG2k)1 were larger due to the larger 
hydrophobic PCL core. Based on the micelle structure, the hydrophobic PCL core was 
expected to incorporate the water-insoluble moieties to stabilize the polyplexes in aqueous 
solution and protect the nucleic acid from degradation in the extracellular environment. 
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Electrostatic interactions between polycationic polymers and nucleic acid, largely responsible 
for the stability of the polyplexes, were strongly influenced by the ionic strength of the 
surroundings [38]. The determination of the colloidal stability was measured by the titration 
of polyplex solutions with concentrated NaCl solution (3 M) and polyplex size was monitored 
by DLS (Fig. 5B). As expected longer mPEG chains, longer PCL segments, larger hy-PEI and 
higher graft density increased the stability of polyplexes due to steric, electrostatic and 
entropic stabilization [39]. Similar results were also reported for lipoplexes [40]. 
In order to demonstrate the stability of polyplexes over time, the size changes of polyplexes of 
hy-PEI25k-(PCL570-mPEG2k)1 were monitored in HBG buffer (supplementary materials 
Fig. 3). The hydrodynamic diameter of polyplexes decreased a little initially and subsequently 
no significant increasewas noticed during the observation time. These results suggest that the 
siRNA polyplexes from hy-PEI-PCLmPEGcopolymers did not aggregate in HBG buffer at 
room temperature. 
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2.4.6. Cytotoxicity assay (MTT) 
MTT-assays were performed in HeLa/Luc cells to evaluate the cytotoxicity of the 
copolymers. Uncomplexed copolymers were used to obtain results for the worst case scenario 
as reported [20]. Four copolymers were selected and hy-PEI25k was used as a control in this 
study. As illustrated in Fig. 6, the cytotoxicity of these copolymers in HeLa/Luc displayed a 
similar concentration dependency as observed in A549 cells [20]. No statistically significant 
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differences in cytotoxicity were found between different polymers in this particular cell line 
which was generated to quantify knock-down effects. However, in other cells, for instance, 
A549 [20] and L929 (not published), the difference can easily be observed. Additionally, a 
trend can be observed according to which unmodified PEIwas more cytotoxic, all copolymers 
with grafting degree 1 behaved very similar, and the copolymer with the highest grafting 
degree of 3 PCL-PEI chains caused the lowest impairment of cell viability. The same trend 
has been described earlierwith an IC50 value of PEI in L929 cells that supported our results in 
HeLa/Luc cells [11]. 
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2.4.7. siRNA transfection 
The same panel of copolymers was then investigated with regard to siRNA transfection 
properties in HeLa/Luc cells under in vitro conditions. Lipofectamine was used as the 
reference [27]. Hy-PEI25k-(PCL900-mPEG2k)1 could be identified as the most efficient 
knockdown agent at N/P 20 and 30 with a statistical significance of p<0.05** and 
p<0.001***, respectively (Fig. 7). At N/P 40, some toxic effects decreased the luciferase 
expression in cells treated with non-specific control siRNA (si-NegCon), which precluded a 
clear statement of the significance of the specific action of the anti-Luc siRNA. However, hy- 
PEI25k-(PCL570-mPEG2k), showed only some luciferase silencing at N/P 20 (p<0.01*) (Fig. 
4 of supplementary materials) although the higher DNA transfection in A549 cells at N/P 10 
was achieved with the same copolymer [21]. Hy-PEI25k-(PCL900-mPEG2k)1 was shown to 
exhibit very good buffer capacity, the highest complex stability and higher zeta-potential 
within the investigated panel, and enhanced siRNA condensation without significantly 
decreased complex size. It is apparent that siRNA transfection efficiency cannot be directly 
predicted based on DNA transfection studies. In this study, the copolymers that showed no 
significant complex stability did not mediate efficient gene knockdown. Since the stability of 
electrolyte complexes in the presence of serum is a major hurdle [26], it is well understood 
that improved complex stability (Fig. 3) and condensation efficacy (Fig. 4), as realized with 
copolymer hy-PEI25k-(PCL900-mPEG2k)1, may be beneficial and apparently more 
important than a decrease of the hydrodynamic diameters below 150 nm. This copolymer 
additionally contains the longest hydrophobic PCL chain amongst the panel investigated. This 
emerging amphiphilic character has previously been shown to be advantageous for 
transfection of amphiphilic, 2´-O-methylated siRNA [41]. The sizes of siRNA polyplexes 
from all these polymers were below 170 nm (Fig. 5A), which was believed to be the 
acceptable size for endocytosis [10]. All the siRNA polyplexes presented net positive surface 
charges (Fig. 5B), which were considered to facilitate uptake by negatively charged cell 
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membranes [10]. Since the difference in gene silencing efficiency of the various complexes 
are not reflected in their hydrodynamic diameter, not only size and surface charge but also 
buffer capacity, and especially colloidal and polyplex stability, as well as cell lines jointly 
affect the siRNA transfection efficiency. Among these factors the stability of polyplexes was 
believed to play a more crucial role than others, not least because increased stability, which 
was earlier accomplished by modification of hyPEI with a long PEG chain of 20 kDa protects 
siRNA against enzymatic degradation and therefore helps the delivery of intact duplexes [12]. 
 
 
 
 
2.5. CONCLUSIONS 
The properties of branched PEI (molecular weight of 25 kDa and 10 kDa) modified with 
mPEG-PCL were investigated in this study. The results revealed the amphiphilic character of 
hy-PEI-PCL-mPEG and the composition dependency of the copolymer properties. Compared 
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with other published works [42], the main advantage of these polymers are the amphiphilicity 
and the controllable stability of polyplexes. In the case of buffer capacity, complex stability, 
siRNA binding affinity, and polyplex stability, the hydrophobic PCL segment and graft 
density exhibited the greatest impact. For instance, hy-PEI25k-(PCL900-mPEG2k)1 and hy 
PEI25k-(PCL342-mPEG5k)3 showed better properties tested in this study than other 
copolymers. Interestingly, hydrophobicity was also shown to play a role in the siRNA 
transfection due to the better polyplex stability despite the formation of larger particles, e.g. 
hy-PEI25k-(PCL900-mPEG2k)1 displayed significant knockdown at N/P 20 and 30 in 
HeLa/Luc cells. Although hy-PEI25k-(PCL570-mPEG2k)1 was the most promising 
copolymer for DNA transfection in our previous studies, no significant siRNA transfection 
was observed for this copolymer in our present experiments. This indicated that the principle 
and results of DNA transfection cannot be directly applied to siRNA transfection. Studies on 
siRNA transfection in vivo, the mechanism of gene transfection with hy-PEI-PCL-mPEG and 
the attachment of different targeting ligands onto hy-PEI-PCL-mPEG will be the subjects of 
our further investigations. 
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2.7. SUPPLEMENTARY MATERIALS 
 
Table 1. Characterization of copolymers in this study. All the percentage of PEI composition 
is based on the weight. 
 
Polymers Feed  
PEI
% 
NMR 
PEI%a 
 
PEI%b 
Mnc Mwc PDIc 
Hy-PEI25k-(PCL570-mPEG2k)1 91 93 91 32270 48224 1.494 
Hy-PEI25k-(PCL570-mPEG550)1 96 96 96 28500 42550 1.489 
Hy-PEI10k-(PCL570-mPEG550)1 90 90 90 15530 18260 1.176 
Hy-PEI10k-(PCL570-mPEG550)3 75 75 77 16320 22310 1.367 
Hy-PEI25k-(PCL900-mPEG2k)1 90 90 89 28410 42690 1.502 
Hy-PEI25k-(PCL342-mPEG5k)1 82 85 87 38130 54290 1.424 
Hy-PEI25k-(PCL342-mPEG5k)3 49 70 78 41430 58070 1.402 
 
a. Calculated from 1H-NMR 
b. Quantified from the titration of copper ions 
c. Obtained From GPC 
1H-NMR (JEOL 500MHz, CDCl3) of hy-PEI-PCL-mPEG: δ 1.36ppm (m, -COCH2CH2CH2CH2CH2O-); δ 
1.63ppm (m, -COCH2CH2CH2CH2CH2O-); δ 2.02ppm (t, -CO-CH2CH2NH-) δ 2.30ppm (t, -
COCH2CH2CH2CH2CH2O-); δ 2.32~3.00ppm (t, -CH2CH2NH-); δ 3.37ppm (s, CH3O-); δ 3.53-3.68ppm (m, -
CH2CH2O-); δ 4.06ppm (t, -COCH2CH2CH2CH2CH2O-); δ 4.20ppm (t, -CH2CH2O-COCH2CH2CH2CH2CH2O); 
δ 4.30ppm (t, -COCH2CH2CH2CH2CH2O- COCH2CH2NH-). 
13C-NMR (JEOL 500MHz, CDCl3) of hy-PEI-g-PCL-b-mPEG: δ 173.08ppm (-COO-); δ 70.49ppm (-
OCH2CH2O-); δ 63.88ppm (-OCH2CH2O-CO-); δ 57.9ppm (CH3O-CH2CH2O-); δ 57.44ppm (CH3O-); δ 
54.41ppm (-N-CH2CH2NH2); δ 52.98ppm (-NCH2CH2NH-); δ 49.45ppm (-NCH2CH2N-);  δ 47.54ppm (-NH-
CH2CH2NH2); δ 41.72ppm (-NH-CH2CH2-NH-);  δ 39.82ppm (-NCH2CH2-NH-);  δ 33.92ppm (-NH-CH2CH2-
NH2); δ 31.33ppm (-CO-CH2CH2NH-);  δ 28.18ppm (-CO-CH2CH2CH2CH2CH2O-);  δ 25.27ppm (-CO-
CH2CH2CH2CH2CH2O-);  δ 24.39ppm (-CO-CH2CH2CH2CH2CH2O-);  δ 22.53ppm (-CO-
CH2CH2CH2CH2CH2O-);   δ 14.00ppm (-CO-CH2CH2NH-). 
 
 
Table 2. pKa values and protonation degree of polymers. α1 stands for the percentage of 
protonated nitrogen atoms; the concentrations expressed here are based on the repeat unit of 
PEI 
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Figure 1. The comparison of the 1H-NMR spectra of hy-PEI25k-(PCL570-mPEG2k)3 and hy-
PEI25k-(PCL570-mPEG2k)1 in deuterated water (D2O) and chloroform (CDCl3) respectively. 
(A): hy-PEI25k-(PCL570-mPEG2k)3 in CDCl3; (B): hy-PEI25k-(PCL570-mPEG2k)3 in D2O; 
(C): hy-PEI25k-(PCL570-mPEG2k)1 in CDCl3; (D): hy-PEI25k-(PCL570-mPEG2k)1 in D2O; 
 
 
Figure 2. Raw data of a representative copper (II) titration curve (Effect of copper (II) amount 
upon complexes formation) 
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Figure 3. The stability of siRNA/ hy-PEI25k-(PCL570-mPEG2k)1 complexes in HBG buffer 
with incubation time at room temperature. The N/P ratios of both are 10. Error bars are the 
standard deviation (SD) of three measurements performed on the same sample. Results shown 
are typical of three separate experiments.  
 
 
Figure 4. Luciferase knockdown in HeLa/Luc cell lines using hy-PEI-PCL-mPEG with 
different compositions at N/P 20 and 30. Solid bars represent the copolymers with anti-
luciferase siRNA; diagonally striped bars stand for the copolymers with non-specific control 
siRNA. Error bars are the standard deviation (SD, n=4; *p < 0.05, **p < 0.01, and ***p < 
0.001). 
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3.1. ABSTRACT 
 
The aim of this study was to investigate non-viral pDNA carriers based on diblock-
copolymers consisting of poly(2-(dimethyl amino)ethyl methacrylate) (pDMAEMA) and 
poly(2-hydroxyethyl methacrylate) (pHEMA). Specifically the block-lengths and molecular 
weights were varied to determine the minimal requirements for transfection. Such vectors 
should allow better transfection at acceptable toxicity levels and the entire diblock-copolymer 
should be suitable for renal clearance. For this purpose, a library of linear poly(2-(dimethyl 
amino)ethyl methacrylate-block-poly(2-hydroxyl methacrylate) (pDMAEMA-block-pHEMA) 
copolymers was synthesized via RAFT (reversible addition-fragmentation chain transfer) 
polymerization in a molecular weight (Mw) range of 17–35.7 kDa and analyzed using 1H and 
13C NMR (nuclear magnetic resonance), ATR (attenuated total reflectance), GPC (gel 
permeation chromatography) and DSC (differential scanning calorimetry). Copolymers 
possessing short pDMAEMA-polycation chains were 1.4–9.7 times less toxic in vitro than 
polyethylenimine (PEI) 25 kDa, and complexed DNA into polyplexes of 100–170 nm, 
favorable for cellular uptake. The DNA-binding affinity and polyplex stability against 
competing polyanions was comparable with PEI 25 kDa. The zeta-potential of polyplexes of 
pDMAEMA-grafted copolymers remained positive (+15–30 mV). In comparison with earlier 
reported low molecular weight homo pDMAEMA vectors, these diblock-copolymers showed 
enhanced transfection efficacy under in vitro conditions due to their lower cytotoxicity, efficient 
cellular uptake and DNA packaging. The homo pDMAEMA115 (18.3 kDa) self-assembled with 
DNA into small positively charged polyplexes, but was not able to transfect cells. The grafting of 
6 and 57 repeating units of pHEMA (0.8 and 7.4 kDa) to pDMAEMA115 increased the transfection 
efficacy significantly, implying a crucial impact of pHEMA on vector-cell interactions. The 
intracellular trafficking, in vivo transfection efficacy and kinetics of low molecular weight 
pDMAEMA-block-pHEMA are subject of ongoing studies. 
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3.2. INTRODUCTION 
 
The field of non-viral gene delivery remains a topic of intensive research efforts, and 
numerous polycations are under investigation [1, 2]. One prominent vector in pDNA delivery 
is poly(ethylene imine) (PEI) 25 kDa, a branched polycation with a high charge density well 
known for its effective complexation, high transfection, but also significant toxicity [3]. To 
improve biocompatibility of PEI, several strategies were pursued such as a reduction of the 
molecular weight [4] or introduction of shielding component, e.g., PEGylation [5, 6].  
As the toxicity of a polymer, among other factors, is related to its charge density [3], 
polycations with more broadly spread charge distribution along the polymer chain, namely 
poly(2-(dimethyl amino)ethyl methacrylate (pDMAEMA) could be of interest. In comparison 
to PEI 25 kDa, pDMAEMA contains only tertiary amino groups, and the charge density is 
lower than in PEI. pDMAEMA shows an average pKa of 7.5 [7], and is thus sufficiently 
protonated at physiological pH for effective polyanion complexation. Previous reports 
described pDMAEMA to possess a decreased proton sponge effect compared to PEI 25 kDa 
[8] implying alternative mechanisms of membrane interaction, such as membrane 
destabilization [9]. This eventually led to reduced cell death, but the polymer retained the 
capacity to escape from endosomes [10].  
A relationship between the polymer-DNA dissociation rate and transfection efficiency was 
established suggesting that pDMAEMA more readily releases DNA from polyplexes than 
polylysine [11]. The class of pDMAEMA was intensively investigated by Hennink and 
coworkers, demonstrating that homopolymers with molecular weights (Mw) of 300 kDa are 
effective DNA-carriers [12]. With increasing molecular weight, its transfection efficiency, 
complexation efficiency but also toxicity increased [10, 13]. Scarce information on the 
performance of low molecular weight (<43 kDa) pDMAEMA is available from the literature, 
although such polymers could possibly be eliminated by renal excretion [9]. Therefore, a 
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library of low molecular weight homo-pDMAEMAs with the chain length varying from 15 to 
23.7 kDa was synthesized and grafted with pHEMA (poly(2-hydroxyethyl methacrylate)), 
resulting in water soluble linear diblock copolymers with a total Mw below 40 kDa. The 
number of tertiary amino groups of the charged copolymer-part exceeds 20 to 30-fold the 
minimal requirement of 4-6 groups reported to be necessary for efficient interaction with 
DNA [14].  
Instead of applying ATRP (atom transfer radical polymerization) [10, 15], in this study, the 
synthesis was performed via RAFT polymerization (reversible addition-fragmentation chain 
transfer) to avoid the use of toxic organometallic catalysts, and to attain narrow polydispersity 
indices (PDIs).  
To improve biocompatibility and colloidal stability, uncharged blocks consisting of pHEMA 
were introduced in an attempt to reduce undesirable adverse interactions such as aggregation 
and cytotoxicity reported previously [16]. PEGylation of pDMAEMA has resulted in a 
decrease of zeta-potential and good steric stabilization of polycations at the cost of poor 
polyplex uptake into cells [17]. Another disadvantage of PEGylation could be seen in an 
“accelerated blood clearance” phenomenon (“ABC”) [18], occurring after repeated 
application of PEGylated vectors due to anti-PEG IgM-production and activation of the 
complement system. The hydrogel-forming pHEMA was earlier reported to be non-toxic and 
water soluble if not cross-linked [19], and biodegradable in linear form [20]. So far, no 
complement activation by pHEMA was reported despite longtime usage in medical 
applications [19].  
Several pDMAEMA-pHEMA vector systems have been investigated recently showing their 
potential as gene delivery systems: blends of pDMAEMA and pHEMA were used to obtain 
nanoparticles [21], polymer with brush-like structures based on short chain pDMAEMA 
grafted on pHEMA backbones by cleavable carbonate ester linkage were reported [15]. Also 
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star shaped pDMAEMAs with cleavable disulfide bonds synthesized via grafting with 
multiple short chain pDMAEMA-arms showed improved transfection efficiency [22].  
Since high molecular weight homopolymers of pDMAEMA (300 kDa) were efficient 
transfection reagents, here, the molecular weight was systematically varied in the range from 
290 to 15 kDa using RAFT to determine the minimal chain length required for transfection 
efficiency. Subsequently, such structures were modified using pHEMA to improve 
cytotoxicity and colloidal stability. These linear diblock copolymers, in contrast to previously 
studied pDMAEMA/pHEMA vectors, were designed to possess very narrow polydispersities, 
a less complicated steric structure and thus better accessibility for charge to charge interaction 
with genetic material, as well as low total molecular weight, allowing renal elimination 
without previous degradation. 
 
 
3.3. MATERIALS AND METHODS 
 
3.3.1. Materials  
Benzyl chloride, Sulfur (80%), Potassium hexacyanoferrate(III), 2-Hydroxyethyl 
methacrylate (HEMA), 2-(Dimethyl amino) ethyl methacrylate (DMAEMA) and 4,4‘-Azobis 
(4-cyanopentanoic acid) (V-501) were purchased from Sigma-Aldrich. Silica gel 60 (0.040–
0.063 mm) for column chromatography (230–400 mesh ASTM) was ordered from Merck 
Chemicals. The dialysis membrane Spectra /Por 6 RC (MWCO 1 kDa) was delivered from 
VWR International GmbH. HEMA and DMAEMA were distilled under reduced pressure 
before use. Poly(ethylene imine) (Polymin™, 25 kDa, abbreviated as PEI 25k) was a gift 
from BASF (Ludwigshafen, Germany). pCMV-Luc (Lot: PF461-090623) was amplified by 
The Plasmid Factory (Bielefeld, Germany). Beetle Luciferin and heparin sodium salt were 
bought from Sigma-Aldrich Laborchemikalien GmbH (Seelze, Germany). SYBR® Gold was 
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obtained from Invitrogen (Karlsruhe, Germany). The Pierce® BCA Protein Assay Kit was 
obtained from Thermo scientific (Schwerte, Germany). All other chemicals not listed were 
obtained from Sigma-Aldrich Chemie GmbH (Seelze, Germany) and used in the highest 
purity if not stated otherwise.  
 
3.3.2. Synthesis  
3.3.2.1 Synthesis of 4-Cyanopentanoic acid Dithiobenzoate (CPT) and Poly (2-(dimethyl 
amino)ethyl methacrylate) (pDMAEMA)  
4-Cyanopentanoic acid dithiobenzoate (CPT), used as chain transfer agent (CTA), was 
synthesized as described in the literature [29]. The synthesis of pDMAEMA, which was used 
as a macroCTA, was performed similarly to the method of Scales et al. [28]. Briefly, 80 mmol 
of DMAEMA were mixed in an ice bath with sodium acetate buffer (pH 5.2) and adjusted to 
pH 5 with HCl. Subsequently, 0.8 mmol of CPT were dissolved in the mixture and either 0.1 
or 0.2 mmol of 4,4´-Azobis (4-cyanopentanoic acid) (V-501) were added. The reaction was 
started by placing the reaction flask into the oil bath pre-heated to 70 °C. To stop the reaction, 
the mixture was frozen in liquid nitrogen after a predetermined time. The polymer was 
purified by dialysis in water, which was adjusted to pH 3–4 with acetic acid. The dialysate 
was changed three times a day during a period of 4 days. The slightly pink-colored polymer 
was dried by lyophilization.  
 
3.3.2.2. Synthesis of Poly (2-(dimethyl amino)ethyl methacrylate)-block-Poly-2-Hydroxyethyl 
Methacrylate Block Copolymers (pDMAEMA-block-pHEMA)  
To synthesize the block copolymer, 0.05 mmol of the macroCTA were dissolved in 5 mL 
sodium acetate buffer and 5 mmol HEMA were added. The amount of 0.125 mmol of V-501 
was added by pipetting 0.25 mL of a freshly prepared stock solution (14 mg/mL) into the 
flask. The reaction was started by placing the reaction flask into in oil bath, which was pre-
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heated to 70 °C. To stop the reaction after a certain time, the mixture was frozen in liquid 
nitrogen. The purification and drying of the block copolymer was performed by dialysis and 
lyophilization as described above.  
 
3.3.2.3. Synthesis of Poly(2-(dimethyl amino)ethyl methacrylate)-Poly-2-Hydroxyethyl 
Methacrylate Random Copolymers (r-pDMAEMA-pHEMA)  
The random copolymers were prepared by mixing different ratios of DMAEMA and HEMA 
in a final volume of 10 mL sodium acetate buffer (pH 5.2) with 0.03 mmol V-501. The 
DMAEMA was therefore dissolved in 5 mL buffer first and adjusted to pH 5 with HCl. The 
reaction was started by placing the reaction flask in an oil bath, which was pre-heated to 70 
°C. After 2.5 h, the reaction mixture was frozen in liquid nitrogen. The copolymer was 
precipitated in THF and dried over night at room temperature. Afterwards, the slightly pink-
colored polymer was dissolved in water and dried by lyophilization. 
 
3.3.2.4. Impurities  
Residues of monomers could be a reason for toxicity of prepared polymers although all 
residues which may originate from the synthesis of the homo polymers and block copolymers 
were removed by dialysis of 40 mL of polymer solution in 10 L distilled water. The water was 
changed three times a day over a period of four days. Monomers left over in the polymer 
solution of random copolymers were separated from the polymer by precipitation of the 
polymer in THF. Residual THF was removed by lyophilization.  
 
3.3. Characterization of Polymers  
The CPT was characterized by 1H, 13C nuclear magnetic resonance (NMR) and attenuated 
total reflectance (ATR) spectroscopy whereas the polymers were also characterized by gel 
permeation chromatography (GPC) and differential scanning calorimetry (DSC). The NMR 
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spectra were obtained with a JEOL GX 400D in either CDCl3, deuterated water, or methanol-
d4. ATR measurements were performed on a Spectrometer of the Excalibur series from Digi-
Lab containing an ATR unit with the WinIR Pro Version 3.3 software in a range between 600 
and 4,000 cm- 1. The GPC system contained a Duratec7505 degasser, Merck-Hitachi HPLC 
system (L6000 pump, AS-2000 auto sampler, T6300 column thermostat), Wyatt Dawn-EOS 
multi-angle laser light scattering detector (calibrated with toluene and normalized with 22 
kDa pullulan standard) and an Optilab DSP refractometer. The columns used for sample 
separation were a PSS 10µ  Novema pre-column and two PSS 10µ  Novema 30 columns of 8 × 
300 mm. The measurements were performed at 35 °C using 1% formic acid as eluent with a 
flow rate of 0.5 mL/min (laser wavelength: 690 nm, cell type: K5). The analysis and the 
calculation of the refractive indices of the copolymers were performed using the Wyatt Astra 
software V5.1.9. The refractive index of pDMAEMA was obtained from the literature [34]. 
The DSC measurements were performed using a DSC 7 unit with TAC7/DX controlling 
station from Perkin-Elmer in a range between -40 °C and 120 °C and a heat rate of 10 
°C/min.  
 
3.3.3. Polyplex Formation  
For transfection, 0.5 µg plasmid DNA (pDNA) in a total of 25 µL polyplex solution was 
applied per well. The polyplexes were prepared by mixing equal volumes of pDNA and 
copolymer in isotonic glucose, calculated to afford the desired N/P ratios (positively charged 
polymer nitrogen atoms per phosphate groups in DNA) as described previously by Liu et al. 
[35]. After mixing by vigorous pipetting, the polyplexes were incubated for 20 min at room 
temperature for complete self-assembly and used freshly. The preparation was scaled up for 
several replicates, so that the total volume (max. 112.5 µL) was later divided into single 
aliquots of 25 µL after incubation, if not stated otherwise. The charge density involved in 
DNA-complexation defined as factor A (g polymer per mol nitrogen) was calculated to be 
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157 g/mol for homo-pDMAEMA and increased with larger percentage of the pHEMA part. 
PEI 25k polyplexes as control were prepared as stated above (factor A = 43 g/mol). 
 
3.3.4. Retardation Efficiency on Agarose Gel & Heparin Competition Assay  
To determine the efficacy of DNA packaging by polycationic polymer, gel electrophoresis 
was used as described previously [36]. For the experiments, 1% agarose gels containing 0.83 
µ g/mL ethidium bromide (EB) were run in TAE buffer (40 mM Tris/HCl, 1% acetic acid, 1 
mM EDTA, pH 7.4) for 45 min at 80 V using an Electro-4 electrophoresis unit, Thermo 
Electron, Waltham, MA, USA. The gels were recorded after irradiation with UV-light using a 
gel documentation system (BioDocAnalyze, Biometra, Göttingen, Germany). The polyplexes 
of different N/P ratios (0.5, 1, 2, 5 for retardation assay, and 15 for heparin assay) were 
prepared as described above, and the volumes of 30 µ L, containing 0.6 µ g DNA were applied 
to each slot. To omit the soaring of polyplexes from the slots and to visualize the migration 
along the lane, 3 µ L of loading buffer containing glycerol and bromophenole blue were added 
immediately prior to application to the gel.  
To test the polyplex stability in the presence of competing anions (simulating serum 
components), they were exposed to heparin of different concentrations for 10 min after the 
usual incubation procedure of 20 min, then applied to the gel with loading buffer. As control 
for the visibility of DNA-EB intercalation, free DNA was run on the gel.  
 
3.3.5. Polyplex size- and Charge-Determination via Dynamic Light Scattering (DLS) and 
Laser Doppler Anemometry (LDA)  
3.3.5.1. Hydrodynamic Diameter and Zeta-Potential of pDNA-Polymer Complexes in Isotonic 
Glucose  
Polyplexes used for this analysis were prepared and incubated as described above. The 
measurements were performed in triplicates for each N/P ratio and polymer. For each 
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hydrodynamic size measurement (DLS), 50 µ L polyplexes were applied directly into a 
disposable low volume cuvette (Eppendorf, Wesseling-Berzdorf, Germany) and analyzed with 
the Zetasizer Nano ZS (Malvern, Herrenberg, Germany) equipped with a 4 mW He-Ne laser 
at a wavelength of 633 nm at 25 °C. The light scattering was detected at a 173° backward 
scattering angle. The parameters of 5% glucose were applied (refractive index: 1.337, 
viscosity 1.0351 cP). For zeta potential measurements, the polyplexes were diluted with 750 
µ L isotonic glucose, applied into a clear zeta U-form cuvette (Malvern, Herrenberg, 
Germany) and analyzed with the Smoluchowski model, with a dielectric constant of 78.5. 
Each sample was measured in 5 runs. For both measurements, N/P ratios of 5, 10, 15, and 20 
were tested and analyzed with the Zetasizer Nano ZS Software 6.20 (Malvern, Herrenberg, 
Germany) as reported previously [37].  
 
3.3.5.2. Influence of Isotonic Salt and Glucose Solutions on Aggregation Behavior of 
Polyplexes (DLS)  
To evaluate the impact of ionic strength of the continuous phase on the aggregation behavior 
of polyplexes, two types of polyplexes were chosen. Polyplexes of the homo-polymer 
(pDMAEMA115) and the diblock-copolymer (pDMAEMA115-block-pHEMA57) were 
measured concerning hydrodynamic diameters over the period of 1 h with 1 min interval 
using DLS. The volume and concentration of polyplexes were chosen according to conditions 
for transfection experiments: 25 µ L complex suspension containing 0.5 µ g pDNA at N/P 15 
were added to 75 µ L isotonic glucose or NaCl-solution after incubation for 20 min and 
measured as described under 3.6. The measurement of each sample was performed twice; the 
mean values and standard deviation are shown in Figure 7.  
 
3.3.6. Cell Culture  
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For transfection experiments, confocal laser scanning microscopy (CLSM) and flow 
cytometry, mouse fibroblasts (3T3) were used that were cultured in DMEM high glucose 
(PAA Laboratories, Cölbe, Germany), supplemented with 10% fetal bovine serum (Cytogen, 
Sinn, Germany). For toxicity experiments, L929 mouse fibroblasts cultured in DMEM low 
glucose (PAA Laboratories, Cölbe, Germany), supplemented with 10% fetal bovine serum 
(Cytogen, Sinn, Germany) were used according to the USP (Unites States Pharmacopoeia) 
cytotoxicity test regulations and according to ISO 10993-5. The incubation of both cell lines 
was performed in a humidified atmosphere with 8% CO2 at 37 °C. For cell experiments, 
passages between 10 and 25 were applied.  
 
3.3.7. Cytotoxicity Assays in vitro  
3.3.7.1. MTT-Cytotoxicity Assay with Polymers  
The toxicity of pDMAEMA-pHEMA diblock copolymers was tested using L929 murine 
fibroblasts in MTT-assays as previously described, using 2mg/mL MTT (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide)-stock solution [38]. As pure 
polymers are considered to be more toxic than the polyplexes [12, 35], the harsher conditions 
were tested by applying the pure polymer dilutions in a concentration range from 0.5 mg/mL 
to 0.00029 mg/mL to 96-well plates with 8,000 cells per well, seeded 24 h prior to the 
experiment. As 100% viability control, untreated cells were used. The IC50 values were 
compared with that of PEI 25k. For each polymer and dilution step, 4 replicates were used. 
After dissolving the metabolically formed formazane crystals in DMSO, the absorbance was 
measured using a plate reader (Titertek plus MS 212, ICN, Germany) at wavelengths of 570 
and 690 nm. For data evaluation, GraphPadPrism 5.0 (Graph Pad Software, La Jolla, USA) 
software was used, the x-scale was plotted logarithmically and nonlinear fit with variable 
slope for data transformation was run to obtain the IC50 values.  
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3.3.7.2. MTT-Cytotoxicity Assay with pDNA-Polymer Complexes  
To directly compare the toxicity of polyplexes to that of polymers only, three 
pDMAEMA115-derivatives were selected and applied to the cells at N/P 15 for 4 h at 
transfection conditions (see Section 3.9. Transfection efficiency). After 4 h of incubation, the 
viability evaluation was performed as described above. Each polymer complex was tested in 
replicates of four.  
 
3.3.7.3. Toxicity via Protein Assay (Bicinchonic Acid, BCA)  
To follow the toxic effect of polymer complexes during the whole transfection period (4 + 44 
h), BCA assays were performed according to the manufacturer‘s protocol (Pierce® BCA 
Assay Kit) parallel to luciferase expression measurements as described below.  
 
3.3.8. Transfection Efficiency  
For transfection experiments, 3T3 cells were seeded at a density of 6,000 cells per well in 96-
well-plates in 200 µ L/well full medium 24 hours prior to transfection. After replacing the old 
medium with 75 µ L of fresh full medium, 25 µ L polyplexes per well, containing 0.5 µ g DNA, 
were added to the cells and incubated for 4 h at normal cultivating conditions. The medium 
was changed 4 hours post transfection to 200 µ L fresh medium, and cells were incubated for 
another 44 hours. After the incubation period, the cells were washed with PBS buffer, lysed 
with cell culture lysis reagent (CCLR, Promega, Mannheim, Germany) and assayed for luciferase 
expression with a 10 mM luciferin solution on a LumiSTAR plate reader (BMG Labtech, 
Offenburg, Germany). In parallel, the lysate samples were analyzed by BCA-Assay according to 
the manufacturer‘s protocol to determine the protein level. Transfections were performed in 
replicates of four, and the results are given as mean values +/-  SD of relative light units (RLU) 
normalized to µ g protein according to the BCA assay.  
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3.3.9. Confocal Laser Scanning Microscopy (CLSM)  
The intracellular distribution of polyplexes was studied by CLSM as described previously 
[36] using 3T3 cells and YoYo-1 labeled pDNA-polyplexes of N/P 15. After standard 
incubation with polyplexes for 4 h, cell fixation and DAPI-staining of cell nuclei followed. 
  
3.3.10. Flow Cytometry  
To quantify the intracellular uptake of copolymers transporting pDNA, flow cytometry was 
employed. 3T3 cells were seeded in 48-well plates at a density of 30,000 cells per well 24 h 
prior to transfection. For this experiment, polyplexes at N/P 15 were chosen as they were 
shown to be most effective for transfection and less toxic than polyplexes at N/P 20. To 
measure pDNA uptake, it was labeled using the intercalating dye YoYo-1 as described 
previously [36]. In short, polyplex preparation was performed as described for transfection 
experiments. 3T3 cells were incubated with the polyplexes for 4 h at 37 °C and afterwards 
washed with PBS. PEI 25k was used as positive control, and as negative control, untreated 
cells were measured. Trypan blue 0.4% in PBS was used to quench the fluorescence on the 
cell surface, allowing for measurement of only internalized YoYo-1 fluorescence. After 
quenching, the cells were washed twice with PBS, trypsinized and fixed with a 1:1 mixture of 
FACSFlow (BD Biosciences, San Jose, CA) and 4% paraformaldehyde in PBS. The single 
cell solutions were measured using a FACSCantoII (BD Biosciences, San Jose, CA) with 
excitation at 488 nm and the emission filter set to a 530/30 bandpass. The gating was adjusted 
to evaluate 10,000 viable cells for each experiment. The results of three independent 
experiments were presented as geometric mean fluorescence intensity (MFI) +/-  SD. Flow 
cytometry analysis was performed using FACSDiva™ software (BD Biosciences, San Jose, 
CA). 
 
3.3.11. Statistics  
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All analytical tests were conducted in replicates of three or four if not otherwise stated. 
Results are given as mean values +/-  standard deviation (SD). Two-way ANOVA and 
statistical evaluations were performed using Graph Pad Prism 5.0 (Graph Pad Software, La 
Jolla, USA) if not stated otherwise. 
 
  
3.4. RESULTS AND DISCUSSION 
 
3.4.1. Synthesis  
3.4.1.1. Synthesis of the Chain Transfer Agent CPT & the Macro Chain Transfer Agent 
(macroCTA) pDMAEMA  
The 1H NMR (nuclear magnetic resonance) spectrum of 4-Cyanopentanoic acid 
dithiobenzoate (CPT) is displayed in Figure 1(A), for the 13C NMR spectrum, see 
Supplementary Information Figure S1. Strong agreement with the literature values was found 
in both cases [23-29]. For this study, four different pDMAEMA homo-polymers designated as 
pDMAEMA97, pDMAEMA105, pDMAEMA115 and pDMAEMA151 were synthesized. 
The index denotes the number of repeating units calculated by NMR measurements. For this 
calculation, the signal of the benzyl group at the end of each polymer strand (7.4–8.1 ppm) 
was correlated with the signal of the two methylene groups of the side chain (3.5–3.6 + 4.4–
4.5 ppm). Shown here are the results from pDMAEMA115 (1) while the other homo-
polymers behaved similarly. The NMR spectra shown in Figure 1(B) corresponds to that 
reported in [9]. In the attenuated total reflection (ATR) IR spectra, the two typical ester bands 
at 1,720 (C=O) and 1,150 (C–O), and the band of the backbone at 2,960 wavenumbers were 
found. 
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3.4.1.2. Synthesis of pDMAEMA-block-pHEMA Block Copolymers (pDMAEMA-block-
pHEMA)  
To calculate the number of HEMA repeating units in the polymer, the signal of the known 
number of methylene groups of the macroCTA was correlated with the signal of the 
methylene groups of HEMA (3.9–4.1 + 4.2–4.3 ppm). This was possible because the signals 
of the different parts do not overlap as displayed in Figure 1(C). Additionally, in the ATR IR 
spectra of the copolymers, the typical band for the hydroxyl group of pHEMA at 3,390 cm- 1 
was found. The ester band at 1,720 and 1,150 cm- 1 belong to both blocks of the copolymer. 
The Tg of pDMAEMA [19] (-6 °C) and pHEMA [21] (~70 °C) are known from the literature 
and decreased, as expected, to lower temperatures for the copolymers with increasing 
pDMAEMA part. The different block copolymers are shown in Table 1. For illustration of the 
synthesis of diblock copolymers, see Scheme 1. 
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3.4.1.3. Synthesis of pDMAEMA-pHEMA Random Copolymers (r-pDMAEMA-pHEMA)  
The synthesis of the random polymers was achieved by simply mixing the monomers before 
starting the reaction. The weights were calculated as described for the macro CTA by 
correlating the signal of the benzyl group with the signal of the side chains of the different 
monomers. Here, the different ratios between the two monomers in the polymer were also 
calculated. The NMR spectra and the ATR spectra were comparable to the ones of the block 
copolymers, as expected. The ratio of the monomers is denoted by the last number in the 
abbreviated term of the polymers as shown in Table 1.  
 
3.4.2. GPC (Gel Permeation Chromatography) Results of the Polymers  
Comparing the values in Table 1, there was a discrepancy between the molecular weight 
calculated by NMR and those values determined by GPC. Since the results for molecular 
weight depend on the way of calculation, a discrepancy between NMR and GPC was expected 
for the copolymers with molecular weights of more than 20 kDa. However, the large 
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differences for the polymers below 20 kDa containing a small amount of pHEMA were 
unexpected. The calculated refractive index was possibly not correct as these copolymers may 
interact with the column material leading to incomplete elution. All the polymers showed a 
PDI around 1, as expected for RAFT polymerization.  
 
3.4.3. Nomenclature of the Synthesized pDMAEMA-block-pHEMA Copolymers  
A library of copolymers containing different amounts of DMAEMA (2-(dimethyl amino)ethyl 
methacrylate and HEMA (2-hydroxyethyl methacrylate) repeating units was synthesized. The 
polymers were designated and classified as shown in Figure 2 (A, B). 
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The synthesized polymers can be divided into three groups: homo-pDMAEMA, linear diblock 
pDMAEMA-block-pHEMA copolymers, and random copolymers with alternating sequence 
of pDMAEMA and pHEMA. The hypothesis for this work was that there would be a lower 
limit of the homo pDMAEMA chain length for effective transfection, and that the lack of 
transfection efficacy could be compensated for by grafting linear pHEMA. A pre-test with a 
panel of homo-polymers with subsequently decreasing pDMAEMA chain length was 
performed in form of in vitro transfections to point out the limit of transfection capacity of 
short chain polycations. Together with cytotoxicity data, the results from the transfection pre-
test of homo-pDMAEMA 15–290 kDa are presented in Figure S2, Supplementary 
Information. It was found that a pDMAEMA95 homopolymer of 15 kDa possessing 95 
repeating units was ineffective in gene delivery, whereas pDMAEMA406 with 64 kDa 
efficiently mediated transgene expression. These findings are in line with earlier studies, 
reporting that a 43 kDa homo-pDMAEMA [9] mediated no significant luciferase expression 
at N/P 8–20, but that the efficacy as vector could be increased at molecular weights above 112 
kDa. Accordingly, in the present study it was found that the pDMAEMA115 homo-polymer 
of 18.3 kDa was inefficient and therefore chosen as low molecular weight ― silent reference 
vector. The copolymers pDMAEMA115-block-pHEMA57 & pDMAEMA115-block-
pHEMA6 synthesized here contain the same polycationic part, but have increased molecular 
weights of 25.7 and 19.1 kDa, respectively, due to pHEMA grafting. Moreover, longer and 
shorter pDMAEMA chains were incorporated into other diblock construct to investigate the 
effect of pDMAEMA-block-pHEMA composition on DNA-complexation, charge, stability, 
toxicity, transfection efficacy and cellular uptake. The random pDMAEMA-pHEMA 
copolymers with larger and smaller polycationic parts were also included in the polymer 
library for investigations of structure function relationships (r-pDMAEMA-pHEMA 4.3–1 and r-
pDMAEMA-pHEMA 1.3–1). The created copolymer library allowed for evaluation of the impact 
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of the pDMAEMA/pHEMA proportion as well as the percentage of the polycationic part in 
relation to homo-pDMAEMA115 concerning vector efficacy in vitro. 
 
3.4.4. DNA Complexation Efficiency  
3.4.4.1. Agarose Gel Electrophoresis  
According to the gel electrophoresis performed with diblock and random pDMAEMA-
pHEMA copolymers (Figure 3 (A–D)), the N/P ratio of 2 was sufficient for complexing and 
immobilizing pDNA in case of all tested polymers. The N/P ratios of 10, 15 and 20 used for 
transfection experiments showed complete retardation of pDNA (data not shown). No 
differences were observed concerning the complexation efficiency of homo pDMAEMA115 
compared to its diblock derivatives with 6 and 57 pHEMA units, and compared to 
pDMAEMA105-block-pHEMA24. Copolymer pDMAEMA151-block-pHEMA91 performed 
similarly as pDMAEMA115, but showed more complete retardation at N/P 1. Copolymer 
pDMAEMA97-block-pHEMA11 performed similarly to pDMAEMA151-block-pHEMA91. 
Yet, the random copolymers and pDMAEMA97-block-pHEMA24 were able to retard DNA at 
N/P 1 already, outreaching PEI 25k in its complexation properties. Based on the obtained gel 
electrophoresis data, all tested low molecular pDMAEMA-pHEMA constructs showed good 
pDNA-complexation even at low N/P ratios. The marginal differences of DNA-retardation at 
N/P 1 may be evidence of the impact of the polymer structure on interactions with pDNA. 
One of these slight differences can be seen in Figure 3(C), where pDMAEMA97-block-
pHEMA24 shows a better complexation of DNA than pDMAEMA97-block-pHEMA11 at 
N/P ratio 1. The efficient complexation ability of the 15.3 kDa polycationic part of diblock 
copolymer pDMAEMA97-pHEMA24 was unexpected, as a 11.1 kDa homo-pDMAEMA was 
reported by Jiang et al. to be a poor complexer [15].  
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3.4.4.2. Heparin Assay — Stability against Competing Polyanions  
The trend observed in gel retardation experiments using polyplexes of lower N/P ratios 
corresponded well with the heparin competition assay of polyplexes at N/P 15 (Figure 4(A–
D)). The copolymers with the same cationic block length of 115 units released DNA upon 
addition of the same heparin amount of 0.46 international units (IU). The copolymers 
pDMAEMA151-block-pHEMA91, pDMAEMA105-block-pHEMA24 as well as 
pDMAEMA115-derivatives appeared to be more resistant to competition with heparin than 
PEI 25k at 0.46 IU heparin, whereas pDMAEMA151-block-pHEMA91 had a less pronounced 
fluorescent band in lane 4 (0.46 IU). The random copolymers and pDMAEMA97-block-
pHEMA11 were even more resistant to the presence of heparin releasing DNA only at higher 
concentrations of 0.93 IU. The highest resistance to competitive polyanions was observed in 
case of pDMAEMA97-block-pHEMA24, where 1.87 IU of heparin was needed to release 
DNA from the complex. Taken together, the most stable complexes were obtained using 
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random copolymers and short chain diblock copolymers with only 97 pDMAEMA units. This 
may be due to a better interaction of copolymers with DNA thus providing a tighter polyplex 
structure. All tested copolymer complexes released DNA at heparin concentrations higher 
than the ones needed for destabilization of PEI 25k polyplexes. This fact can be interpreted as 
an advantage for protecting genetic material, but as well as a disadvantage, as far as DNA 
release is concerned at the site of action. Accordingly, decreased DNA release may cause 
reduced transfection efficiency of the most stable complexes. 
 
 
 
3.4.5. Size and Zeta Potential  
3.4.5.1. Size and Zeta Potential of Polyplexes in Isotonic Glucose  
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Isotonic glucose solution was used to formulate polyplexes with pDNA. For complete self-
assembly of polyplexes, a 20 min incubation time was maintained after mixing. In 
measurements after shorter or no incubation, higher polydispersity indices and larger complex 
sizes were obtained (data not shown). PEI 25k yielded DNA-polyplexes in the size range 
<100 nm at all N/P ratios. At N/P ratios of 10, 15 and 20, the polyplex sizes of pDMAEMA-
block-pHEMA diblock copolymers did not show statistically significant differences in 
hydrodynamic diameters compared to each other. All polymers were able to complex pDNA 
into polyplexes with hydrodynamic diameters of 100–170 nm. This is considered a size range 
suitable for cellular uptake [31, 32]. Larger polyplexes were formed only in case of 
pDMAEMA105-block-pHEMA24 at N/P ratio 10, which may be due to complexation 
irregularities reflected in the broad standard deviation (Figure 5 (A)). The hydrodynamic 
diameter of naked plasmid was earlier reported to be in the range of 300–400 nm [12].  
The zeta potentials of polyplexes from diblock copolymers ranged from 10 to 30 mV 
depending on the N/P ratio (Figure 5 (B)). A significant increase of the zeta potential at N/P 
20 was only registered for pDMAEMA105-block-pHEMA24 and r-pDMAEMA-pHEMA 
1.3:1. In general, no reduction in positive charge density could be observed for pHEMA-
grafted copolymers in comparison to homo-pDMAEMA, suggesting that the pHEMA chains 
may not be localized on the polyplex surface but closer to the core of pDMAEMA and pDNA. 
The polyplex size also remained in the range of homo-pDMAEMA complexes with no 
obvious disturbance of complexation caused by grafting of pHEMA. Additionally, Figure 6 
(A, B) demonstrates similar trends in polyplex size and zeta potential concerning 
pDMAEMA115-derivatives. 
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3.4.5.2. Polyplex Aggregation Behavior in Isotonic Salt and Glucose Solution over Time  
According to the measurements of hydrodynamic diameters of polyplexes incubated in 
isotonic glucose and NaCl solution, similar trends were observed for pDMAEMA115 and 
pDMAEMA115-block-pHEMA57. In glucose, both polymer types showed good stability of 
their polyplexes with pDNA (Figure 7). In high ionic strength solution, on the contrary, 
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significant polyplex aggregation could be observed and larger sized constructs appeared over 
time. From the aggregation experiment it may be expected that both types of polymers 
behaved similarly in cell experiments, as polyplexes of both types aggregated rapidly in the 
presence of high ionic strength medium. However, the Hennink group previously reported 
that the transfection efficiency of pDMAEMA polyplexes was not decreased in spite of an 
observed increase in size in the presence of serum [10, 12]. 
 
 
 
3.4.6. Cytotoxicity of Polymers and Polyplexes in vitro (MTT, BCA)  
Cytotoxicity data obtained with MTT assays in L929 mouse fibroblasts indicated a better 
biocompatibility of pDMAEMA-pHEMA diblock copolymers with IC50 values 1.4–9.7 times 
higher than that of PEI 25k, depending on the polymer structure (Figure 8 (A,B)). Comparing 
the IC50-values of the homo-polymers within the library synthesized here, the 18.3 kDa 
homo-pDMAEMA was nearly five times less toxic (IC50 = 0.043 mg/mL) than 290 kDa 
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pDMAEMA (IC50 = 0.009 mg/mL) (Figure S2, Supplementary Information). These results 
were not unexpected as it has been described earlier that the toxicity of homo pDMAEMAs is 
a function of the molecular weight of the polycation [10]. Cherng et al. [12] reported an IC50-
value of 0.03 mg/mL determined in XTT-assays for a pDMAEMA homo-polymer of Mw/Mn 
of 36 × 104/45 × 103 Da in COS-7 cells. Due to the very broad polydispersity (Mw/Mn) of 
the polymer, however, it cannot easily be compared with the RAFT polymers reported here 
which all feature PDI values below 1.20 (Table 1). Copolymer pDMAEMA105-block-
pHEMA24 was 9.7-fold less toxic (***p < 0.001), and pDMAEMA115-block-pHEMA57 was 
7.9-fold less toxic (**p < 0.01) than PEI 25k. The lowest IC50 values were obtained with r-
pDMAEMA-pHEMA 4.3–1 being only 1.4 times less toxic than PEI 25k. The differences in 
toxicity between the different diblock-copolymers and homo-pDMAEMA solutions in the 
Mw range of 17–35.7 kDa (exposure for 24 h, Figure 8 (A,B)), and between complexes with 
pDNA and solutions of pure pDMAEMA115 homo- or co-polymers (exposure for 4 h, Figure 
9) were found to be not significant. The polymers pDMAEMA97-block-pHEMA11 and r-
pDMAEMA-pHEMA 1.3–1 showed some irregularities in biocompatibility with mouse 
fibroblasts, resulting in very broad toxicity ranges. These irregularities could possibly be 
caused by residual impurities from the synthesis (see ―  Materials and Methods Section 3.4.2. 
for more details). To further investigate toxicity issues, the protein analysis (BCA assay) 
following transfection experiments was conferred (see Figure 10). In this assay, a clear trend 
of decreasing protein values related to blank could be observed towards higher N/P ratios, 
correlating well with earlier described results [9, 10]. As reported previously, cell membrane 
destabilization may be one of the reasons for cytotoxicity [9, 10] and is connected with the 
charge density. The homopolymer pDMAEMA, however, has a lower charge density than PEI 
25k. Additionally, grafting of uncharged pHEMA may contribute to the deviation from a 
linear trend of pDMAEMA-toxicity as a function of the chain length. The toxicity of random 
copolymers r-pDMAEMA-pHEMA 4.3–1 which was notably higher than that of diblock 
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copolymers as observed in both MTT and BCA, correlated well with higher polycation 
content. Surprisingly, no significant differences were found concerning toxicity between 
pDMAEMA115-derivatives applied as polyplexes or pure polymers of the same concentration 
(Figure 9). However, Cherng et al. also observed only a partial ― neutralizing effect of 
polymer toxicity by plasmid for homo-pDMAEMA of Mw/Mn of 36 × 104/45 × 103 Da in 
COS-7 cells [12]. PEI 25k was much more toxic as pure polymer than its pDNA complexes 
(Figure 9), which is in line with earlier reports describing ―  charge neutralization in 
polyplexes being able to decrease the toxicity of PEI [33].  
The mechanism of interaction of diblock- and random-copolymers with cellular membranes 
as well as further optimization of the HEMA block-length for better biocompatibility is 
currently under investigation. 
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3.4.7. Transfection  
Based on the results of the physico-chemical characterization of pDMAEMA-pHEMA 
polyplexes concerning polyplex size distribution, zeta potential and complexation efficiency, 
none of the polymers from the tested panel could be excluded as candidate for transfection. 
However, the in vitro transfection experiments using pDNA encoding for luciferase in 
comparison to PEI 25k as standard presented a different picture. The obtained relative light 
units (RLU) related to µ g protein were statistically evaluated using two-way ANOVA 
comparing them to blanks. Free DNA did not mediate significant luciferase expression 
compared to untreated cells (data not shown). Therefore, in further experiments, untreated 
cells were used as blanks. The p-values are indicated on the bar heads with stars (*p < 0.05; 
**p < 0.01;***p < 0.001). At N/P 10, only one efficient candidate (pDMAEMA151-block-
pHEMA91) that caused significantly higher transgene expression than naked DNA was 
observed apart from PEI 25k (see Figure 11). At higher N/P ratios two additional candidates 
were identified mediating significant transgene expression (pDMAEMA115-block-
pHEMA57, pDMAEMA115-block-pHEMA6). As expected from previous reports, where 43 
kDa pDMAEMA was not successful in transfection [9], the homopolymer pDMAEMA 
consisting of 115 repeating units (18.3 kDa) was found to be an ineffective transfection agent 
at all tested N/P ratios. On the other hand, its derivatives pDMAEMA115-block-pHEMA57 
and pDMAEMA115-block-pHEMA6 with Mw of 25.7 and 19.1 kDa, respectively, provided 
transfection efficiency at higher N/P ratios, whereas Jiang et al. only achieved moderate 
transfection results with brushed pDMAEMA-pHEMA copolymers far above 75 kDa at N/P 6 
[15]. The diblock copolymers with slightly higher pDMAEMA content (151 units, total Mw 
of 35.7) were able to mediate transfection already at N/P 10. The random copolymer r-
pDMAEMA-pHEMA 1.3–1 (29.0 kDa) yielded no statistically significant luciferase 
expression over the whole N/P-range tested. Thus, it can be assumed that one of the factors 
essential for transfection is the number of charged repeating units incorporated within the 
  113 
 
diblock copolymer, as a clear trend of increasing transfection efficacy towards higher homo-
pDMAEMA molecular weights was already observed earlier [9, 10]. The candidates 
possessing only 105 or even 97 pDMAEMA repeating units in a pDMAEMA-pHEMA 
diblock were ineffective, probably due to the lack of positive charge needed to perform 
transfection. This data strongly agree with the pre-test transfection experiment where homo- 
and diblock copolymers with 95 and 110 units pDMAEMA were tested and showed RLU 
values only at blank level (diblock copolymers data not shown, for homopolymers see Figure 
S2 Supplementary Information).  
The unexpected observation that low molecular weight pDMEMA achieves transfection 
efficiency only after conjugation with pHEMA in a block structure points to the fact that 
interaction with cells is affected by this arrangement. It was reported that pHEMA possesses 
good tissue affinity [19] and may therefore have additional ― fusogenic interactions with 
cellular membranes enhancing the uptake of polyplexes. The candidates, pDMAEMA151-
block-pHEMA91 and pDMAEMA115-block-pHEMA57, being successful in transfection 
carry rather long pHEMA blocks. The w/w proportion of pDMAEMA:pHEMA blocks for 
pDMAEMA151-block-pHEMA91 was 1.7:1 and for pDMAEMA115-block-pHEMA57 2:1, 
suggesting that a two-fold excess of the polycationic part is favorable for transfection. In case 
of pDMAEMA115-block-pHEMA6, the proportion was 19:1 and for r-pDMAEMA-pHEMA 
4.3–1 4.3:1, leading to effective transfection only at one N/P ratio (N/P 20 and 15, 
respectively). Taken together, the most promising copolymers were found to contain at least 
18.5 kDa of the polycationic part grafted to pHEMA in a pDMAEMA:pHEMA proportion of 
2 to 1. The efficacy of random copolymers was observed to grow with increasing poylcationic 
part. The favorable impact of pHEMA on transfection efficacy is being further investigated.  
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3.4.8. Uptake Efficiency  
To gain a more detailed insight into the cell uptake of polyplexes from diblock copolymers, 
uptake efficiency was tested with fluorescently-labeled DNA in the same cell line as used for 
transfection at an N/P ratio of 15 (Figure 12). The geometric mean fluorescence intensity 
values (MFI) obtained in flow cytometry experiments were found to be in agreement with the 
transfection results. Layman et al. observed no influence of pDMAEMA length on cellular 
uptake in the molecular weight range from 43 to 915 kDa [9]. In this study, however, all 
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pDMAEMA-pHEMAs successfully transfecting 3T3 cells were taken up to a higher degree 
than the “silent” ones, suggesting that uptake is a critical step for these polyplexes. The structural 
analysis implies a favorable effect of pHEMA on cell affinity correlating well with previously 
reported findings [19], since the pDMAEMA115-derivative with a longer pHEMA-graft was taken 
up to a higher extent than the one with only 6 pHEMA units. Additionally, pDMAEMA151-block-
pHEMA57 was also effectively taken up. PEI 25k showed a lower MFI due to its higher toxicity 
and thus higher percentage of dead cells not gated in the experiment. The same could be 
speculated regarding r-pDMAEMA-pHEMA 4.3:1. 
 
 
 
3.4.9. Subcellular Distribution (CLSM, Confocal Laser Scanning Microscopy)  
After internalization of polyplexes, the intracellular distribution is of importance. Confocal 
microscopy was performed to characterize the intracellular polyplex distribution 4 h post 
exposure to the cells. YoYo-1 labeled pDNA is displayed in green, and DAPI stained nuclei 
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appear blue, the cell membranes are visualized with transmitted light. The images of all three 
channels are superimposed.  
For this study, polyplexes of diblock copolymers with the most prominent transfection 
efficiency were depicted at an N/P ratio of 15. In all cases the green fluorescence was clearly 
observed in the perinuclear area, inside the nucleus as well as diffusely in the cytoplasm. This 
confirms an effective uptake within the period of 4 hours. Since microscopy does not allow 
for quantitative analysis, only representative images of transfected cells are shown in Figure 
13. Cells treated with PEI-pDNA complexes appeared to be less intensively fluorescent. This 
may be related to the higher toxicity of PEI 25k at N/P 15 or to the fact that there was less 
fluorescently labeled DNA in the cytosol, but the DNA was translocated to the nucleus. 
Especially in cells treated with polyplexes of copolymers, broadly disseminated fluorescence 
as well as dot-formed green was present. This reflects the presence of polyplexes captured in 
endosomes as well as pDNA released into cytoplasm. Presence of fluorescence in the 
perinuclear area and inside the nucleus is a good predisposition for effective transfection. 
Layman et al. showed successful cellular uptake of polyplexes made of pDMAEMA 915 kDa 
as early as 30 min after application [9]. However, at that time point, only dotted increments 
were found, indicating endosomal capture of the polyplexes. 
  117 
 
 
 
 
3.5. CONCLUSIONS 
It was shown in this study that the in vitro transfection ability of low molecular weight 
pDMAEMA  18.3 kDa could be improved by grafting low molecular weight pHEMA. The 
high molecular weight homo-polymers were established as effective pDNA vectors by the 
Hennink group [10, 12], with the lower limit for efficient homo-polymers being 43 kDa as 
reported by Layman et al. [9]. In agreement with these findings, no transfection for 18.3 kDa 
homo-pDMAEMA at N/P ratios up to 20 was observed in the experiments described here. 
Accordingly, this polymer was used as ― negative control, whereas its transfection efficiency 
was succesfully improved by grafting pHEMA. Efficient transfection could be achieved with 
homo-pDMAEMA of 64 kDa (see Supplementary Information Figure S2). The central idea of 
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this project was on the one hand to create non-viral vectors with molecular weight below the 
kidney elimination limit suitable for excretion without previous degradation, and on the other 
hand decreasing the vector‘s toxicity by reducing the molecular weight of the polycationic 
part. This approach of improving biocompatibility was successfully performed by Jiang et al. 
[15], using a pHEMA backbone grafted with cleavable short pDMAEMA-chains, resulting in 
vectors of molecular weight over 75 kDa. In this present study, the molecular weight of 
efficient copolymers was successfully decreased to 30–35 kDa. The diblock pDMAEMA-
block-pHEMA bearing only 115 pDMAEMA repeating units became an active transfectant 
after grafting with pHEMA to the total molecular weight of 19 kDa. The diblock copolymers 
bearing less than 115 polycation units could not be improved in transfection efficacy despite 
of pHEMA-grafting. Based only on physicochemical characteristics of the polyplexes (size, 
zeta potential, and complexation ability), no discrimination between “active” and “inactive” 
copolymers for DNA transfection could be made, all tested copolymers were potentially 
appropriate for gene delivery, possessing favorable complexation, cellular uptake and DNA-
packaging. Only in transfection experiments, the potential as gene vectors could be 
discriminated. The cellular uptake and intracellular distribution strongly agree with 
transfection data, underlining the importance of the ― charge and ― total Mw balance. The 
pHEMA-grafting implies to be favorable for polyplexes in terms of cellular interaction and 
uptake. The toxicity of the homo-polymers was in good correlation with the pDMAEMA 
block length and thus with charge density. Concluding, the low molecular weight linear 
diblock pDMAEMA-block-pHEMA constructs starting from 19 kDa and possessing at least 
18 kDa pDMAEMA, are promising candidates for further investigations in the field of gene 
delivery. Ongoing studies on in vivo transfection experiments, mechanistic aspects of 
complexation, and kinetic inside the cell are currently under investigation. For cell-type 
specific transfection, coupling of targeting ligands is being discussed. 
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Polymer Conformation in Aqueous Solution is Critical for 
DNA-Vector Formation: Isothermal Titration Calorimetry and 
Molecular Dynamics Disclose Causes for Variability in 
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Abstract:  
 
Low molecular weight poly(2-(dimethyl amino)ethyl methacrylate-block-poly(2-hydroxyl 
methacrylate (pDMAEMA-b-pHEMA) block-copolymers have been proposed as potential 
gene delivery agents. The interrelation between structure, biocompatibility and transfection 
efficacy has been described previously. However, reasons for variable transfection efficacy 
within this polymer family remained unclear, apart from beneficial effects of the pHEMA 
segment. This study investigates the energetic aspects of polymer-DNA binding by means of 
isothermal titration calorimetry (ITC), and simulates polymer chain behaviour in water via 
computational molecular dynamics (MD).  
Polymer chain flexibility as reflected in the glass transition temperature (Tg) appeared to be 
important for binding thermodynamics, as depicted in ITC enthalpy profiles. The Tg increased 
with growing pHEMA chain length. The Tg above the room temperature reduced the chain 
flexibility, favouring the formation of hydrogen bonds between polymer and sorrounding 
water molecules according to Collets protein folding theory (Collet O. J. Chem. Phys. 2011; 
134(8):85101-85107). Therefore, pHEMA-rich structure was fixed in a more stretched form 
in solution. The hydrogen bonds to the solvent molecules counteracted folding, herewith 
providing better accessibility for positive charge to DNA.  
Evaluating the nanovehicle self-assembly process according to mechanistic criteria of 
polymer conformational state and subsecquent DNA-binding thermodynamics, this study 
could define high Tg as advantageus polymer parameter favourable for transfection efficacy of 
a low molecular weight pDMAEMA-b-pHEMA polymer family. The combined use of ITC 
and MD principles presented here can be interesting for examination of other linear materials 
for gene delivery application. 
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1. Introduction 
 
In the course of creating optimal non-viral vectors for gene and drug delivery, many strategies 
have been exploited, adjusting diverse polymer parameters such as branching grade [1-3], 
charge density [4], linkage of components with different physico-chemical properties [5, 6] 
represented in the entire variety of chemical structures [7, 8]. To be efficient in its mission of 
cargo delivery, it is essential for a drug or gene carrier to fulfil a range of requirements, such 
as low toxicity, high complexation efficacy, enzyme degradation resistance, and capability for 
endosomal escape, among others [9]. One of the questions arising from the very first 
technological step of vector preparation is: how does the polymeric structure behave in a 
solvent environment? Does it have a preferred conformation in solutions? A further question 
is how possibly existing conformational transitions can be controlled, and how well do these 
conformational states assemble with intended cargo? How can we predict these 
conformational states based on information from chemical structure for more productive 
carrier tailoring? Adequate and sufficiently sensitive methodology is required to carry out this 
versatile polymer investigation.   
Isothermal titration calorimetry (ITC) is a highly sensitive and precise measuring 
methodology to characterize ligand binding. It is based on the registration of released or 
absorbed heat of interaction and can be employed for an elaborate analysis of thermodynamic 
processes of association. A detailed overview of measurement principles and performance 
capacities of one of the first computerized ITC-instruments was given by Wiseman et al. as 
early as 1989 [10]. Nowadays, ITC has established itself in a broad range of applications, 
including the characterization of micellar systems, interactions of drugs, polymers and 
proteins with surfactants, the association of nucleic acids with multivalent cations, 
nanoparticle characterization, as well as the improvement of targeting ligands as reviewed 
lately by Bouchemal [11]. Several previous studies have already attempted to describe this 
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problem in respect to transfection efficacy. Thus Choosakoonkriang et al. studied the aspects 
of PEI/DNA complexation, searching for a relationship between physical characteristics and 
transfection efficacy. In his study both DNA circular dichroism spectra and ITC monitored 
polymer-DNA binding interaction, as well as polyplex stability examined via differential 
scanning calorimetry showed no direct correlation to transfection performance in cells. No 
DNA conformation change was observed for any of the PEI structures [12]. Nandy et al. 
simulated PAMAM/DNA interaction computationally, studying the compaction impact of 
different generation dendrimers on DNA. The binding strength correlated with polymer 
charge intensity and thus with dendrimer generation. The G3 and G4 dendrimers were more 
flexible and showed deformation upon binding to DNA, being also less efficient. All 
generations preserved the native B-form DNA structure [13]. Also for siRNA the interaction 
of dendritic molecules characterized via ITC and molecular dynamic simulation was 
published by Jensen et al [14]. Here a good applicability of this technique was shown: 
simulated rigid sphere behaviour of siRNA of G7 dendrimer, favourable for complexation of 
siRNA, was in line with experimental data.  
Despite broad availability of information on polymers with more complex structures, the short 
linear co-block polymers have so far been rather scarcely investigated. Here, we focus on 
linear polymer structure and its conformational aspects, using the pDMAEMA homo- and 
pHEMA-diblock-copolymer family as example. The low molecular weight pDMAEMA-b-
pHEMA diblock copolymers have previously shown considerable capability for transgene 
expression in vitro [15]. The dependency between performance in cell culture and varying 
pHEMA-part in polymeric structure could be clearly demonstrated. Nevertheless, the definite 
reasons for superior performance of pHEMA-containing vectors are still to be understood.  
This question has become the objective of this study. Selected candidates from the 
pDMAEMA/pHEMA polymer family were explored regarding their mechanistic aspect, using 
a combinational method of isothermal titration calorimetry (ITC) and molecular dynamic 
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simulation (MD). The ITC was used to characterize the binding interaction between polymer 
and DNA from an energetic point of view. The MD was applied to assess the conformational 
rearrangements of polymers in an aqueous environment. The grade of hydrogen bonds 
development between polymer and solvent molecules and its depandance on glass transition 
temperature Tg will be discussed from the view of Collet’s protein folding theory in water. 
[16].  
 
 
2. Materials and Methods 
 
2.1. Materials 
Polymers for his study were synthesized in via RAFT polymerization as described previously 
[15]. Poly(ethylene imine) (Polymin™, 25 kDa, abbreviated as PEI 25k) was a gift from 
BASF (Ludwigshafen, Germany). For titration experiments herring testes DNA, Type XIV 
was obtained from Sigma Aldrich Chemie GmbH (Seelze, Germany).  
 
2.2. Isothermal titration calorimetry of DNA with polymers 
Isothermal titration calorimetry (ITC) was applied for the investigation of energetic effects 
detected as heat flow during the polymer-DNA binding process. Both ligands, herring testes 
DNA (HT-DNA) and polymers, were prepared in double distilled filtered water from pure 
lyophilized substances without any additives. The ITC measurements were conducted with a 
MCS titration calorimeter (Microcal, Inc., Northhampton, MA) at a temperature of 25°C. 0.03 
mM HT-DNA, based on phosphate, was applied in a temperature controlled measurement 
cell. Polymer solutions ranged from 0.55 to 5.5 mM based on nitrogen.  Prior to application to 
the cell or syringe respectively, both components involved in titration were degassed under 
vacuum and with stirring for 7-10 minutes, to avoid artefacts due to gas bubbles and hence 
possible disturbances of the base line. Polymer was titrated from a 250 µL syringe to DNA in 
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steps, with 250-300 seconds between injections, to return the temperature to the base line after 
the registration of the binding heat of each injection peak. The first injection volume was set 
at 4 µL and not involved in the further data evaluation to avoid possible inaccuracy due to 
syringe filling etc.; further injections were set at 6 or 8 µL and repeated at least 15 times 
during one titration run to achieve the DNA-saturation with polymer. Each sample 
measurement was performed at least twice. ITC-data were analyzed with ORIGIN Software 
(Microcal Inc.) to prepare final isotherms. 
 
2.3. Molecular dynamics (MD) simulation 
The three-dimensional polymer structures of pDMEAMA-derivatives were modelled using 
MOE [17] and were used as input for molecular dynamic simulations, which were performed 
with the AMBER 11 software suite [18]. The force field parameters were computed using the 
antechamber program. Amber coordinate, parameter and topology files were generated by 
xleap and the generalized Born solvation model [19] was applied. The resulting systems were 
minimized and equilibrated at 300 K for 1 ps using 10 Å cutoff. The simulation time was 20 
ns, at 300 K and 1 atm with a time step of 1 fs and no cut-off. All simulations were carried out 
by the  pmemd.cuda module of the AMBER 11 suite on a single GPU. Dynamic trajectories 
analysis and geometric data clustering were performed with ptraj. Graphical representations 
of the polymer molecules were prepared using PyMOL [20]. 
 
2.4. Laser Doppler Anemometry (LDA) 
For zeta potential measurements, polymer solutions of 2.75 mM based on nitrogen were 
freshly prepared in twice distilled filtered water. The measurement was performed in a clear 
zeta cuvette (Malvern, Herrenberg, Germany) at 25°C, and analyzed using the Smoluchowski 
model. Each polymer was measured three times, the amount of runs and the attenuator 
position were adjusted automatically. The data were presented in relative values, setting the 
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maximal zeta potential signal equal with the maximally stretched polymer form. Decreasing 
charge signals were given as per cent of stretched form charge availability and represented 
indirectly the folding state of the counted molecule.  
 
2.5. Differential scanning calorimetry (DSC) 
The glass transition temperature Tg was determined by menas of a DSC device composed of a 
DSC-7 unit and a control station TAC7/DX (Perkin – Elmer, Waltham, USA). For the 
measurement, 10 mg of lyphilized substance were sealed in an aluminium DSC pan. The 
measurement data were obtained from the second heating cycle. The minimal cycle 
temperature was -40°C and the maximal 120°C, the heating rate was 10°C/min. The data were 
evaluated with Pyris Software Version 4.01 (Perkin – Elmer). 
 
2.6. Transmission electron microscopy (TEM) 
For morphological evaluation of polymer-DNA complexes, 10µL of polyplex formulation 
were applied to a carbon copper grid (S160-3, Plano, Wetzlar), incubated for 10 minutes, 
blotted with filter paper and dried overnight.  The final polymer concentration in preparation 
was about 0.2 mg/mL. Prior to complexation with DNA, the polymer was incubated with 
Copper (II) sulphate in a proportion of about 1µg polymer to 1.4 µL 3% copper solution. The 
OH-groups of pHEMA complexed Cu2+ ions and increased the coiled polymer chain 
electronic density, improving visibility in TEM (JEM-3010 TEM, JEOL, Eching). The 
measurement was performed at 300 kV. 
 
 
3. Results and Discussion 
 
 
3.1. Thermodynamic monitoring of Polymer-DNA association process (ITC) 
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To study the binding interaction between components capable of self-assembly, isothermal 
titration calorimetry [10] was applied here.  A binding process is accompanied by changes in 
heat flow, the direction and intensity of which is dependant on structural features of the 
interacting components. During step by step addition of polymer to DNA, the spontaneous 
thermodynamic process of vector formation can be registered in form of peak signals 
following each injection, detectable until the DNA-saturation point is reached and the signals 
drop to the base line. 
For the thermodynamic study five polymers were selected: poly(ethylene imine) (PEI) 25 
kDa, a well established branched transfection agent of high performance [12, 21], 
pDMAEMA115 (linear polymer with 115 pDMAEMA repeting units), previously “silent” in 
transfection, and three linear diblock copolymers pDMAEMA115-b-pHEMA6 , 
pDMAEMA115-b-pHEMA57 and pDMAEMA151-b-pHEMA91 whose transfection efficacy 
improves along with increasing co-part of pHEMA [15].  
Despite the principally equivalent process of polymer-DNA self-assembly, three different 
types of heat flow profiles could be registered during titration (Fig.1). The purely exothermic 
profile (downward peaks) was obtained for PEI 25k, the purely endothermic (upward peaks) 
profile for homo-pDMAEMA, and a combined exothermic-endothermic profile for 
pDMAEMA-b-pHEMA diblock-copolymers. The molarity of titration solutions was based on 
nitrogen charge of polymers (+) and phosphate charge of DNA (-). In the final product – a 
nano-vehicle suspension, at a certain nitrogen to phosphate ratio (N/P) was generated. 
Depending on the amount of HEMA-repeating units grafted to the pDMAEMA-block, the 
point at which the heat flow switched direction moved towards higher or lower N/Ps.  The 
most prolonged exothermal interaction was achieved during titration of pDMAEMA115-b-
pHEMA57 and pDMAEMA151-b-pHEMA91 to DNA (switch-point at N/P of 8-11 and 6-8 
respectively). pDMAEMA115-b-pHEMA6 had the shortest exothermal titration segment 
(switch-point already at N/P 4-5).  
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For PEI 25k, the interaction process was completed already at N/P 2.5-3. All pDMAEMA-
derivatives, on the contrary, interacted beyond the charge neutralization point with significant 
amplitude of heat signal registered until N/P 18-20. 
Attempts to interpret the uneven heat flow profiles are known from earlier ITC studies 
involving polymers and genetic material.  Wankee et al., for instance, assigned different ITC-
phases to DNA conformational transition during polymer binding, and the DNA state changed 
from an elongated to a collapsed form [22].  Jensen et al. studied siRNA interaction with 
PAMAM, and interpreted the appearance of the second phase in ITC-curve at higher N/P 
ratios as aggregation process [14]. Privette et al. experienced the heat flow switch from 
endothermic to exothermic direction with poly(amidoamine)-derivatives and DNA and also 
assigned the later interaction phase to the aggregation process; aggregation was supported 
with dynamic light scattering data and subtracted from further ITC analysis [23].  
The segmentation of ITC profile into two enthalpic phases with different sign, in the present 
study, can neither originate from DNA-conformational changes nor from the nano-vehicle 
aggregation or sedimentation process. The circular dichroismus spectra (Fig.S1, Appendix) do 
not give any evidence of any DNA conformation transition: the native B-form, slightly 
altered, was maintained for all tested polymers over a broad N/P range. The dynamic light 
scattering and zeta potential data show no abrupt change in size, charge or PDI at the heat 
flow switch points of the ITC-curve (Fig. S2, Appendix). Both interacting components 
applied for titration were lowly concentrated (0.0099 mg/mL DNA, 0.0237 mg/mL PEI 25k 
and up to 0.123 mg/mL pDMAEMA-derivatives depending on structure), thus providing good 
solubility of titration products up to higher N/Ps.  
We assign the enthalpy direction switch in ITC curve profile to polymer conformational 
changes. Hendriksen et al. observed similar thermodynamic transitions and interpreted them 
as structural rearrangements of peptides during interaction with lipid membranes [24]. Such 
transitions during interaction of polymer with genetic material, to our knowledge, have not 
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been studied previously. In this study the energetically favourable initial phase (exothermic) is 
likely to represent the stretched form of pDMAEMA-derivatives, during which polymer 
nitrogen atoms are easily accessible for interaction with DNA.  After this polymer 
conformation is exhausted due to DNA-binding, the interaction with a coiled polymer form 
begins. This interaction is accompanied by an energy-intensive (endothermic) chain de-
folding process, making nitrogens accessible for contact with DNA. This unfavourable 
segment has to be compensated by increasing entropy of the reaction system to allow 
spontaneous material assembly after de-folding [25].  
PEI 25k is a less flexible polymer, retaining its conformation in solution [26], due to which 
the sterical accessibility of nitrogens to DNA does not change over the whole titration period. 
The pDMAEMA115, on the contrary, has an energetically unfavourable start and must 
support the binding interaction by investing energy into the de-folding process. The diblock 
copolymers combine both processes, switching to endothermic interaction after utilization of 
freely available stretched form. More details regarding conformational state, reasons for 
conformational changes and charge accessibility are discussed in further sections.  
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Figure 1: Isothermal titration calorimetry profiles, titration of 0.03mM HT-DNA with 0.55 
mM PEI 25k (A), 5.5 mM pDMAEMA115 (B), 2.75 mM (C I) and 5.5 mM (C II) 
pDMAEMA115-b-pHEMA57, 4 mM (D I) and 5.5 mM (D II) pDMAEMA115-b-pHEMA6, 
2.75 mM (E I) and 5.5 mM (D II) pDMAEMA151-b-pHEMA91 
 
 
3.2. Energetically preferred polymer conformation state in water (MD and ZS)  
For MD simulations, one polymer without and two polymers with different amounts of 
HEMA-repeating units were selected: pDMAEMA115, pDMAEMA115-b-pHEMA6 and 
pDMAEMA115-b-pHEMA57. The polymer chain rearranged itself considerably during the 
MD simulation. In order to obtain representative frames of each polymer’s geometric 
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movement, dynamic trajectories were clustered into 10 groups. The clustering procedure was 
based on the root mean square deviation (RMSD) of the polymer’s backbone atom 
coordinates. The RMSD is a commonly used method for measuring the average distance 
between atoms of two molecules. Results from the cluster analysis clearly demonstrate that 
during the simulation stretched polymers collapse into more energetically favorable globular 
conformations, however, the polymers gain the final energetically favourable state on 
different time scales (Fig.2). This final conformation is most likely to be the polymers’ 
“natural state” upon dissolution in water. Any geometrical rearrangements of this 
conformational state would be energetically unfavourable and therefore require energy 
investment. 
For each frame which emerged from the clustering analysis, the water accessible surface area 
[27] for atoms with positive partial charge (ASAplus) was calculated by MOE [17]. 
According to these calculations the accessibility of charges on the molecule surface decreased 
from 100% (related to the first frame) to 63% for pDMEAMA115-b-pHEMA57 and to about 
40-50% for pDMAEMA115-b-pHEMA6 and pDMAEMA115 final conformations (last 
frame) (Fig.3). The length and width of the polymer chains in linear and coiled conformation 
changed even more drastically (Tbl.1). For example the length of pDMAEMA115-b-
pHEMA57 contracted itself nearly 4.1-fold from 36.97 nm to 9.11 nm, of homo-pDMAEMA 
about 4.4-fold (26.28 to 6.12 nm). 
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Figure 2: Molecular dynamic folding frames of pDMAEMA115-b-pHEMA57 (A) and 
pDMAEMA115 (B) during the MD simulation. The collapse of both polymers proceeds on 
different time scales. pDMAEMA115-b-pHEMA57 reaches the final frame after 10.4 ns and 
pDMAEMA115 after 7 ns.  
 
 
Figure 3: Reduction of overall positive charge accessibility upon molecule folding over 10 
frames. The surface area with positive partial charge (ASAplus) accessible for water has been 
computed by MOE and is shown as a value relative to the first frame of the MD simulation 
(A). Accessible surface after maximal folding (B). 
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 stretched form folded form 
Name long (nm) across (nm) long (nm) across (nm) 
pDMAEMA115 26.28 1.46 6.12 3.99 
pDMAEMA115-b-pHEMA6 23.67 2.39 5.61 3.57 
pDMAEMA115-b-pHEMA57 36.97 1.61 9.11 3.76 
 
Table 1: Distances between the most remote points of molecules in stretched (first frame) and 
folded state (last frame), determined from MD simulation. 
 
 
 
To assess the conformation state distribution in a practical experiment, the zeta potential of 
polymer constructs available in water were measured. Due to the folding of polymer chains, 
overall accessible nitrogen charge declined. Thus the most stretched state appeared the most 
charged, the most coiled appeared least charged. The highest value of zeta potential of each 
polymer measured in water solution was related to the unfolded polymer molecule state 
(100% nitrogen charge accessibility). The presence of molecules with lower zeta potential 
was interpreted as polymer chain folding, resulting in partial sterical blockage of charge. The 
distribution of polymer chain conformations in water could be indirectly accessed 
experimentally via zeta potential measurement, and zeta potetial/folding state correlation 
building (Fig.4). According to these findings, PEI 25k molecules had a single distribution 
peak with about 80% charge availability. This was expected, as PEI 25k is a globular 
molecule of branched structure and rather inflexible, representing a single conformation state 
[26]. All three pDMAEMA-derivatives showed multi-peak distributions. pDMAEMA115 had 
the broadest distribution of conformational states, probably due to the highest chain flexibility 
and dynamicity in solution. Its derivatives with 6 and 57 pHEMA repeating units were more 
clearly split into two conformational states, one smaller, representing the stretched state, 
another with a higher amount of counts. For pDMAEMA115-b-pHEMA6 and 
pDMAEMA115-b-pHEMA57 the final folded state with about 43 and 48 % of the total 
charge availability. Homo-pDMAEMA also had a second peak at 43% charge availability, 
with the highest peak appearing at about 63%, which corresponds to a middle folding frame 
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of MD. The zeta potential data deviated slightly from the MD charge availability prognosis, 
and are likely to give a more dynamic picture with intermediate folding states. The findings 
resulting from both methods agree in that the folding does not undershoot the charge 
accessibility of 30% for all tested polymer structures. Comparing the absolute zeta potential 
values, it is important to underline that the maxima of PEI 25k and pDMAEMA115-b-
pHEMA57 mostly overlap, which  may be an indicator of optimal charge availability as they 
were both superior in transgenic expression [15] (Fig.S3, Appendix).  
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Figure 4: The zeta potential of polymer solutions in water (2.75 mM based on nitrogen) was 
measured, the highest value for each polymer was assigned to the unfolded polymer molecule 
state with 100% charge accesibility. Charges beneath this value represent polymer molecules 
in a more folded state, where nitrogen charges are partly sterically blocked.  
 
 
3.3.    Glass transition temperature of polymers (Tg) 
Usually the glass transition temperature Tg is used as a parameter indicating the mobility of 
polymer chains. Here we make use of another effect described in detail by Collet et al. in 
relationship to protein folding in water [16]. According to Collet, the stability of hydrogenic 
bonds between some compound and solvent molecules depends on the Tg of this compound. 
The higher above the solvent temperature the Tg is, the more likely it is for hydrogenic bonds 
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to remain intact. Bonds to the surrounding environment protect the compound from sterical 
collapse, letting it retain a more stretched geometry. Above the Tg, the hydrogen bounds 
rupture spontaneously and compound chains turn into a “natural” coiled state. This 
phenomenon applies to pDMAEMA-derivatives, as the pHEMA content increases the Tg. 
Pure pHEMA has a Tg about 70°C [28], homo-pDMAEMA about -6°C [29]. The 
pDMAEMA115-b-pHEMA6 has a Tg of 23°C, which predestined the large part of chains to 
fold in water at 25°C. This behaviour could be traced in MD during this study. The 
pDMAEMA115-b-pHEMA57 with Tg of 53°C was less folded according to computer 
stimulation in comparison to pDMAEMA115-b-pHEMA6. The branched polyethyleneimine 
25 kDa (PEI 25k) was not simulated in MD. Even though its Tg is a lot lower (-25°C) [30, 
31], it does not follow this folding rule due to its highly branched and inflexible structure 
[26].  
 
 
Figure 5: Glass transition temperature (Tg) of pDMAEMA-derivatives depending on 
pDMAEMA/pHEMA proportion in diblock, room temperature (RT) is indicated as horizontal 
dotted line 
 
 
3.4.  Depiction of  “patchy” polyplex structure 
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As the dynamic light scattering could only give an idea concerning the size, but not 
concerning the shape and morphology of polymer complexes with DNA (polyplexes), 
transmission electron microscopy (TEM) was able to fill this gap (Fig.6). In TEM images the 
polyplexes appeared as constructs with an irregular boundary line in about 100 nm size range, 
which is in agreement with dynamic light scattering measurements (DLS) (Fig. S2, 
Appendix). Moreover, the polyplexes appear to have a “patchy” surface structure. The 
polyplex increments with higher electronic density sized 5-10 nm were expected artefacts, 
representing the coiled polymer conformations associated with a polyplex surface. The 
presence of folded pDMAEMA-b-pHEMA57 chains in the solution was already indicated by 
the polymer conformation state in water (MD, DLS). The excess of polymer at N/P15 did not 
allow the polymer chains to make tight contact with DNA, here only adsorptive attachment of 
folded polymer chains occurred. In ITC curve, the N/P 15 is situated on a falling endothermic 
heat flow slope, indicating the energetically expensive de-folding process to decrease here.  
 
 
 
Figure 6: Transmission electron microscopic pictures of pDMEMA115-b-pHEMA/DNA 
complexes of N/P 15, the structures with irregular contour are polyplexes, rounded increments 
of 5-10 nm are coiled polymer chains on their surface (A). Hydrodynamic diameters of 
pDMAEMA115 (a), pDMAEMA115-b-pHEMA57 (b) and PEI 25 kDa (c) complexes with 
DNA, N/P ratios taken directly from ITC titration curve and hence uneven (B). 
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4. Conclusions 
 
In this study we could shed light on the mechanistic differences of the self-assembly process 
of low molecular weigth homo-pDMAEMA and pDMAEMA-b-pHEMA block-copolymers 
with DNA. The folding behavior of polymers in solution and their binding thermodynamics 
correlated well with the previously described differences in transfection performance.  
The conformational state of linear molecules was proven to be critical for self-assembly with 
DNA. The availability of a stretched conformation with the highest nitrogen accessibility was 
essential for energetically favourable interaction with DNA and correlated with the glass 
transition temperature Tg. The pHEMA-rich methacrylate derivatives with higher Tg were the 
“energetically cheapest” interaction partners as revealed by ITC. Due to their ability to retain 
more hydrogen bonds to solvent molecules than homo-pDMAEMA, they remained fixed in a 
more stretched conformational state as MD could show. The de-folding process had 
endothermic character and most probably had to be compensated by entropy increase to allow 
a spontaneous self-assembly reaction. This means that the linear polymers are handicapped 
for DNA-binding, as they are preferably in a folded state in solutions. 
Here we introduced a possibility to explore the polymer-DNA self-assembly process using 
both ITC and MD methodology elucidating polymer characteristics benefitial for transfection 
purposes. Establishing correlation between polymer flexibility and favourable binding 
energetics can be recommended as an effective and sensitive approach for further 
development and evaluation of non-viral vectors for gene therapy and drug delivery.  
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SUPPLEMENTARY MATERIALS 
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Figure S1: Circular dichroismus spectra of PEI 25k Da (A), pDMAEMA115 (B), pDMAEMA115-b-pHEMA57 
(C) with DNA complexes at different nitrogen to phosphate ratios (N/P). Native DNA is added as reference in 
each graph (black line). N/P 7 and 15 for PEI not shown, as there was no ITC signal, thermodynamic interaction 
ended before N/P 3. 
  
 
 
 
Figure S2: Zeta potential, Size and PDI data of polymer-DNA complexes, N/Ps are matching the titration steps 
in ITC.  
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Figure S3: Absolute values of zeta potential of polymer 2.75 mM solutions in water 
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CHAPTER 6 
 
___________________________________________________________________________ 
 
Summary and Outlook 
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SUMMARY 
 
In this thesis, novel polycationic vectors for therapeutic gene delivery were introduced with 
the focus on structure-function relationship in both physicochemical and biological aspects. 
First the transfection related differences of classical vectors with high and low branching 
grade and charge density: PEI and PLL, were examined under pH-alternating tumor tissue 
conditions. Further structural design for siRNA delivery was proposed on base of PEG-PCL-
PEI multifunctional self-assembly ABC-construct, showing the importance of total 
hydrophilic-lipophilic balance for efficient gene silencing performance. For DNA delivery a 
new low molecular weight di-block pDMAEMA derivative was synthesized and 
characterized, proving it to be a low toxic and efficient vector. The relationship between 
pHEMA-content and polymer chain flexibility was assessed via molecular dynamics 
simulation (MD). The thermodynamic polymer-DNA binding characteristics, monitored via 
ITC, appeared to depend on glass transition temperatue (Tg).  The use of both MD and ITC 
methodologies provided new information on the cargo-carrier self-assembly process in 
solution, relevant to transfection performance of diblock-copolymers.   
 
Chapter 1 introduced to the general goals and executive instruments of gene therapy, as well 
as potentially addressable disease scope, with a special focus on cancer treatment. The pH-
alteration and cell cycle phase impact on transfection process in tumor tissue, as well as EPR-
effect were discussed. Advantages and requirements on polycationic gene carriers were 
presented, followed by short portrait of classical polymers with their advantages and 
optimisation needs. Strategies of vector optimisation were discussed following the ways of 
prolonged circulation, toxicity decrease and modified membrane activity.  
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Chapter 2 investigated the impact of environmental pH on transfection efficacy of polymeric 
carriers on example of classical representatives PEI and PLL. Both transfection and culture 
medium were varied from physiological to pathologically lowest pH-condition, proceeding in 
four steps: 7.4, 7.0, 6.7, and 6.3. Physicochemical and biological parameters either showed 
significant alternations in respond to pH-shift. The effects were partly oppositely directed, as 
it could be monitored in separated medium- and transfection pH-conditions. Compared to 
physiological conditions, acidic transfection medium reduced gene expression 1.6~7.7-fold, 
whereas acidic culture medium enhanced transfection efficiency 2.1~2.6-fold at the same 
time. Findings of this study strongly suggest to take tumor acidity in consideration when 
developing materials for gene carrier purposes. The specific biological charcteristics of 
acidified tissue should also not be neglected, as they modify transfection efficacy 
performance.  
 
Chapter 3 analyzed the structure-function relationship of mono-methoxyl-poly(ethylene 
glycol)-block-poly(ε-caprolactone) (mPEG-PCL) modified hyperbranched PEI copolymers 
(hy-PEI-PCL-mPEG) as vectors for siRNA delivery. These ABC constructs were amphiphilic 
and could build stable polyplexes. The PCL-segment length as well as PCL-PEG-grafting 
density had the most noticable impact on buffer capacity, colloidal stability and siRNA 
binding affinity. From a library of (hy-PEI-PCL-mPEG) polymers, hy-PEI25k-(PCL900-
mPEG2k)1 was distinguished as the most successful candidate for siRNA delivery making it 
perspective for in vivo experiments. 
 
In Chapter 4 the block-lengths and molecular weights of poly(2-(dimethyl amino)ethyl 
methacrylate-block-poly(2-hydroxyl methacrylate) family were varied to determine the 
minimal requirements on polycationic part for transfection. The lower limit was set with 
homo-pDMAEMA of 115 repeating units. The homo-pDMAEMA115 was ineffective in 
  149 
 
transfection, its performance in vitro was increased significantly with pHEMA-grafting. The 
RAFT-synthesized diblock copolymers were in the range of 17–35.7 kDa, being 1.4–9.7 times 
less toxic than PEI 25 kDa and potentially extractable via kidney without prior degradation 
need. Here the low molecular weight pDMAEMA polymers, previously believed to be 
unsuitable as DNA vectors, were improved in their transfection capability keeping the toxicity 
in acceptable range, making them attractive candidates for further investigation in terms of 
therapeutic gene delivery.  
 
In Chapter 5 the correlation between polymer rigidity, pHEMA-content and glass transition 
temperature (Tg) was determined. The ability to retain stretched conformation in solution, 
demonstrated with MD, reflected the conformational state importance in interaction with 
DNA, where the energetical aspect of binding was assessed with ITC. Highly flexible homo-
polymer molecules required additional energy investments for de-folding process prior to self-
assembly with DNA to form a functional nano-vehicle. The correlation of preferentially 
exothermic ITC-profiles with pHEMA-co-block length underlined repeatedly the beneficial 
effect of pHEMA-grafting on transfection performance improvement.  The findings about 
polymer structure-dependant conformational state in water and the polymer thermodynamic 
speciality of interaction with DNA could explain the differences in transfection performance 
observed previously.  
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OUTLOOK 
 
Basing on the results described in Chapters 2 to 4, strategically different ways of farther gene 
delivery candidates investigations can be followed. The knowledge obtained on impact of 
acidified tumor tissue conditions on polymeric transfection in Chapter 2 can be propagated 
on a broader range of more complex polycationic carriers like PEG-PCL-PEI for siRNA form 
Chapter 3 or pDMAEMA-pHEMA for DNA delivery from Chapter 4. This option may 
disclose more details on vector specificity in transfection conditions nearer to pathological 
situation and hence help optimize the vector design in a more directed way.  
Another important step for vectors proven to be efficient in vitro is to launch to the animal 
experiment phase. The factors essential for the perspective to join clinical studies should be 
obtained: biocompatibility, biodistribution and circulation time etc. 
For more precise understanding of intermolecular interactions and sterical effects of 
polycationic carriers on DNA and siRNA interaction ITC and MD studies are reasonable 
including the comparative siRNA/DNA binding study as well as thermodynamical screening 
of binding potential under different conditions (varying ionic srength-, serum protein content 
and medium pH) to uncover potential handicaps of synthesized constructs. 
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ZUSAMMENFASSUNG 
 
In der vorliegenden Arbeit wurden innovative polymerische Vektoren, die für die 
Durchführung von Gentransfers entwickelt gewesen sind, vorgestellt. Hierbei richtete sich der 
besondere Akzent auf den Zusammenhang zwischen Struktur und Funktion sowohl aus 
physikalisch-chemischen als auch  biologischen Blickpunkten. Zuerst wurden die für eine 
Transfektion relevanten Unterschiede von klassischen Vektoren mit hohem und niedrigem 
Verzweigungsgrad - PEI und PLL - unter alternierenden pH-Bedingungen von Krebsgewebe 
untersucht. Weiter wurde strukturelles Design für siRNA-Transfer auf Basis von PEG-PCL-
PEI,  einem multi-funktionellen selbst-assoziierenden ABC-Konstrukt, mit Betonung der 
Wichtigkeit der gesamten Hydrophilie-Lipophilie-Bilanz für effiziente Stilllegung der 
Genfunktion vorgeschlagen. Für Transport und Zustellung von DNA wurde ein neuer  
niedermolekularer diblock pDMAEMA-Abkömmling synthetisiert und charakterisiert, 
wonach der Vektor sich als effizient und geringfügig toxisch erwiesen hat. Der 
Zusammenhang zwischen pHEMA-Gehalt und Flexibilität der Polymerkette konnte mittels 
Dynamischer Simulation (MD) aufgeklärt werden. Die Besonderheiten zu 
thermodynamischen Aspekten von Polymer-DNA Bindung, die an die Glaspunkttemperatur 
(Tg) gekoppelt zu sein scheinen, wurden mittels ITC beobachtet. Sowohl die MD als auch die 
ITC- Methodiken lieferten neue Informationen zum Cargo-Carrier- 
Selbstorganisationsprozess in Lösung, welche wichtig in Bezug auf  die Transfektionsleistung 
der Diblock-Copolymere sind.  
 
Kapitel 1 stellte die allgemeinen Ziele und Ausführungsinstrumente der Gentherapie sowie 
die potenziell adressierbaren Krankheiten mit besonderem Akzent auf Krebstherapie vor. Hier 
wurden die Einflüsse von verschiedenen Zellzyklusphasen bei alternierenden pH-Werten auf 
den Transfektionsprozess im Tumorgewebe sowie der EPR-Effekt diskutiert. Die 
Anforderungen an polykationische Genvektoren wurden dargestellt, gefolgt von einem kurzen 
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Portrait der klassischen Polymere mit deren Vorteilen und Optimierungsnotwendigkeiten.  
Optimierungsstrategien für Vektoren wurden in Bezug auf verlängerte Zirkulation, 
Toxizitätsminderung und modifizierte Membranaktivität erörtert. 
 
Kapitel 2 beschäftigte sich mit der Untersuchung der Einflüsse von Umgebungsazidität auf 
die Effizienz von polymerischen Genträgern am Beispiel der klassischen Vertreter PEI und 
PLL. Sowohl  das Transfektions- als auch das Kultivierungsmedium wurde von der 
physiologischen bis hin zur pathologisch niedrigsten Azidität - in vier pH-Stufen 7.4, 7.0, 6.7, 
und 6.3 - variiert. Die physikalisch-chemischen und biologischen Kenngrößen zeigten beide 
bedeutende Veränderungen als Reaktion auf den pH-Shift.  Wie es sich aus der Betrachtung 
der Kultivierungs- und Transfektionsmedien unter getrennten Bedingungen abgezeichnet hat, 
waren die Effekte teilweise entgegen gerichtet.  Das angesäuerte Transfektionsmedium 
verringerte die Genexpression um etwa 1.6~7.7-mal im Vergleich zu physiologischen 
Bedingungen, wobei das angesäuerte Kulturmedium gleichzeitig die Transfektionseffizienz 
um etwa 2.1~2.6-mal erhöhte. Die in dieser Studie erworbenen Befunde zeigen, dass die 
Berücksichtigung des aziden Milieus in der Tumorumgebung  sehr empfehlenswert bei der 
Materialentwicklung für Gentransportzwecke ist. Die spezifischen biologischen 
Eigenschaften von azidem Gewebe sollten  nicht  vernächlässigt werden, weil sie die 
Transfektionsleistung beeinträchtigen. 
 
Kapitel 3 untersuchte den Zusammenhang zwischen Struktur und Funktion von mit Mono-
methoxyl-poly(ethyleneglycol)-block-poly(ε-caprolacton) (mPEG-PCL) modifizierten hoch 
verzweigten PEI-co-polymeren (hy-PEI-PCL-mPEG) als siRNA-Vektoren. Die ABC-
Konstrukte waren amphiphil und konnten stabile Komplexe bilden. Die PCL-Segmentlänge  
sowie die PCL-PEG-Armanzahl hatten meist deutlichen Einfluss auf Pufferkapazität, 
kolloidale Stabilität und Bindungsaffinität zu RNA. Aus der Biblothek von (hy-PEI-PCL-
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mPEG) Polymeren hat sich hy-PEI25k-(PCL900-mPEG2k)1 als erfolgreichster Kandidat für 
den Transport von siRNA hervorgehoben und somit Perspektiven für Tierexperimente 
eröffnet. 
  
In Kapitel 4 wurden die Blocklängen und Molekularmassen der poly(2-(dimethyl 
amino)ethyl methacrylate-block-poly(2-hydroxylmethacrylate)-Familie variiert, um die für 
eine erfolgreiche Transfektion notwendigen Mindestanforderungen an den polykationischen 
Anteil zu bestimmen. Durch pHEMA-Kopplung konnte das bis dahin zu 
Transfektionszwecken unbrauchbare homo-pDMAEMA115 bedeutend in seiner in vitro 
Leistungsfähigkeit verbessert werden. Die mittels RAFT synthetisierten Diblockcopolymere 
lagen im Bereich von 17–35.7 kDa und waren um 1.4–9.7-mal weniger toxisch als PEI 25 
kDa sowie auf Grund ihrer Größe für renale Ausscheidung ohne vorherige Metabolisierung  
geeignet. Somit wurden die niedermolekularen pDMAEMA - früher als erfolglose DNA-
Vektoren bezeichnet - in deren Transfektionspotential bei gleich niedriger Toxizität gestärkt, 
was sie zu interessanten Kandidaten für weitere Untersuchungen in Rahmen der 
therapeutischen Genzuführung macht. 
 
In Kapitel 5 wurde die Wechselbeziehung zwischen Polymersteifigkeit, pHEMA-Anteil und 
Glaspunkt-Temperatur (Tg) bestimmt. Der mittels MD im Wasserkraftfeld simulierte 
Faltungsprozess der Polymerketten reflektierte die Bedeutung der Polymerkonformation 
während der DNA-Bindung. Mittels ITC konnten auch die energetischen Aspekte dieses 
Bindingsprozesses ersichtlich gemacht werden. Hoch flexible Moleküle des Homopolymers 
benötigten eine zusätzliche Energieinvestition für den Entfaltungsprozess, um mit DNA zu 
funktionstüchtigen Nanovehikeln assoziieren zu können. Der Zusammenhang zwischen dem 
hohen Anteil an exothermen Segmenten in ITC-Profilen  und der Länge des pHEMA-co-
Blocks betonte zum wiederholten Male den günstigen Einfluss der pHEMA-Anknüpfung auf 
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die Transfektionseffizienz. Die Befunde über den Zusammenhang zwischen Polymerstruktur, 
dessen räumlicher Anordnung in Wasser, und der Besonderheit der thermodynamischen 
Bindung dieser Polymerkonformation zu DNA könnten Aufschluss über die zuvor 
bobachteten Varitionen in Transfektionseffizienz geben.  
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AUSBLICK 
 
Basierend auf den in Kapitel 2 bis 4 beschriebenen Ergebnissen können weitere 
Untersuchungen im Bereich Gentransfer in strategisch verschiedenen Richtungen verfolgt 
werden. Die in Kapitel 2 gewonnenen Erkenntnisse über den Einfluss von sauren 
Bedingungen im Tumorgewebe auf die  polymerische Transfektion können auf ein weiteres 
Spektrum noch komplexerer polykationischer Trägersysteme ausgebreitet werden, wie z.B. 
PEG-PCl-PEI für siRNA aus Kapitel 3 oder  pDMAEMA-pHEMA für DNA-Transfer aus 
Kapitel 4. Diese Vorgehensweise kann mehr vektorspezifische Details über die 
Transfektionseffizienz in pathologisch nahen Bedingungen offenbaren und somit zu einer 
feineren und gezielteren Gestaltung der Vektoren beitragen.  
Ein anderer wichtiger Schritt ist der Übergang zur tierexperimentellen Phase mit in vitro als 
erfolgreich etablierten Polymeren. Die für die Teilnahme an klinischen Studien erforderlichen 
Parameter, wie z.B. Bioverträglichkeit, Bioverteilung und Zirkulationsdauer, sind noch zu 
ermitteln.  
Zum detaillierteren Verständnis von intermolekularen Interaktionen und sterischen Effekten     
polykationischer DNA- und siRNA-Träger sind weitere ITC- und MD-Studien sinnvoll, 
inclusive der Vergleichsstudie von siRNA/DNA-Polymer-Bindung, sowie 
thermodynamischem Screening des Bindungspotentials unter unterschiedlichen Bedingungen 
(variierende Ionenstärke, Serumproteingehalt und Medium-pH), um  potentielle Engpässe der 
synthetisierten Konstrukte aufzudecken.   
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